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INTRODUCTION 
 The Siddha system of medicine is a gift to mankind by ancient Siddhars. 
Siddha system is basically related to the composition of the Universe and the 
human beings. Nothing can separate them individually; all are interrelated with 
each other. 
 The other systems of medicine, deal only with the prevention and the 
treatment of the disease. But our Siddha system of medicine not only deals with 
prevention and treatment but also prolongs the longevity of human life and also 
improves the quality of life. This is explained by Thirumoolar in Thirumanthiram 
800 as follows, 
              “kWg;gJly; Neha; kUe;njdyhFk; 
       kWg;gJs Neha; kUe;njdr;rhYk; 
             kWg;gjpdp Neha; thuhjpUf;f 
            kWg;gJ rhitAk; kUe;njdyhNk” 
 The significance in Siddha medicine is the three humors (three thodam) 
theory. The humors (thodam) are vatha, pitha, and kaba. Diseases are explained as 
a disturbance in the equilibrium of the above said three humors. When these are in 
perfect balance and harmony, a person is said to be healthy. 
    “kpfpDq; FiwapDk; Neha; nra;Ak; EhNyhh; 
  tspKjyh vz;zpa %d;;W” 
          -jpUf;Fws; 
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 In Siddha system, the theory of Pancha Bhutham plays a major role in all 
aspects. The skin is also formed by the Pancha Bhutham. Skin is one of the 
components of prithivi (earth).  
This is mentioned as 
       ‘Nrug;gh rlkhr;R kz;zpd; $W 
                                 nrwpkaph; Njhy; vd;gpiwr;rp euk;ige;jhFk;” 
     -  rjf ehb. 
 Skin is formed by the combination of Mann+ Theyu. So if any 
derangements in theyu and its components such as sleep, thirst, appetite, firmness 
and unification, may affect the skin by disturbing the function of Saaram, 
Senneer, Oon and Kozhupu.                         
                            ‘thj kyhJ Nkdp nflhJ” 
  So if any derangement in Vatha, may cause the skin hard and rough, black 
and reddish with intense pain. Man highly reflects the surrounding. Tactile 
sensation is achieved by the skin, with the help of vayu and it is also mentioned 
as, 
                   “tsg;gq;Nfs; G+kp trpf;Fk; ehrpapy; 
       fsg;gkhk; td;dp jhDwq; fz;zpdpy; 
               msg;gkhk; Nghtlq;fpLk; ehtpdpy; 
       gsg;g ey;thATk; ghprpf;Fnkq;FNk 
                  vq;fpa fhjpypUe;JW khjhak;” 
- jpU%yh; ehb 
 If the function of kapha is altered in the body by the food and activities, it 
will lead to pallor of the skin and shiny or glossy appearance with intense pain. 
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 Skin or integument is closely related with internal and external 
environments.  If any changes occur with in the body or in the environment it is 
reflected immediately over the skin by features like dryness, itching, etc., because 
skin acts as the linking media between the body and outer world. Skin is closely 
related with mind and soul. Slight distress and strain may cause pathological 
changes in the skin.  
  Eczema is the common problem all over the world. The incidence is about 
2-3%. Eczema is a non contagious inflammation of the skin characterized by 
erythema, scaling, oozing and vesiculation. Eczema is a specific type of allergic 
cutaneous manifestation of antigen antibody reaction. It has been revealed that 
persons living in urban areas, working in industries and residing near industries, 
labours and farmers, changing lifestyles and food habits, allergic sensitive 
individual who suffer from diet and cosmetics are all commonly affected.  
Seven types of are Karappan recognized in Yugi Vaithiya Chinthamani. 
Among the classification of karappan, the author have selected Vatha karappan for 
the clinical study of the dissertation work on the basis of siddha concept on course 
of the disease, diagnosis, prognosis, dietic and preventive aspects . 
Vatha Karappan, which can be compared with Eczema, is one of the most 
common skin disease encountered in medical practice all over the world. If it is not 
diagnosed early and given proper and adequate treatment, it may lead to chronic 
condition. It is a highly socio-stigmatic skin disease which upsets an individual 
both physically and mentally.  
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 The author hopes that this work on Vatha Karappan would provide better 
information of the clinical trial with the selected drug undertaken at Government 
Siddha Medical College, Palayamkottai, with all available sources provided here. 
 
Drug of choice: 
1. Internal use 
 Perumarapattai chooranam 1gm with water three times a day. 
 Reference: Agasthiyar 2000 third part. Pg.no73 
2. External use 
 Pungu thylum 
 Reference: Yugimuni Vaithiya kaaviyam.Pg.no 299 
  The author has reveals her study about the disease Vatha Karappan 
in the following pages.  
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AIMS AND OBJECTIVES 
Karappan is a dermatological disease that causes many patients in despair. 
It is a major health hazard in the developing countries like India. People who live 
in densely populated areas with poor hygiene facilities, lack of personal and 
environmental hygiene, change in life style, diet habits, and use of artificial 
cosmetics, chemical constituents are the common factors that precipitate this 
disease. So when the disease once occurrs, remission and relapse happens 
subsequently throughout the life of the patient. The frequency of relapse depends 
upon the individual immune power. 
  The author has selected this disease for the dissertation work to evolve a 
better treatment for getting rid of this disease, once for all. When selecting an 
appropriate drug to try, the author had decided to go for a pure herbal drug 
Perumarapattai chooranam internal and Herbo Mineral drug Pungu thylum 
external. 
1. The principal object of this study is to have a clinical trial on Vatha 
Karappan patients with trial drugs Perumarapattai chooranam (internal) 
and Pungu thylam (external). 
2. To create awareness about the Siddha science and to highlight the efficacy 
of Siddha drugs among the public. 
3. To have an idea of an incidence of Karappan with reference to age, life 
style, occupation, socio economical status, family history, and seasonal 
variations. 
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4. To know how the disease alters the normal conditions under the topics of 
Mukkutram, Poripulangal, Envagai thervugal, Udar kattugal, Neerkuri and 
Neikuri. 
5. To evaluate the biochemical and pharmacological analysis of the trial drugs. 
6. To use the modern diagnostic parameters to endorse the diagnosis and 
follow the progression of the disease. 
7. To make an awareness among the people about the prevention of the 
disease.  
8. To know the extent of correlation of etiology, classification, signs and 
symptoms of Vatha Karappan in Siddha aspect with Eczema in modern 
aspect. 
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REVIEW OF LITERATURES 
SIDDHA ASPECTS 
fug;ghd; 
,ay; (Definition): 
 clypy; jpkph;> jpdT> nrhwp> Gz;> jbg;G> ntbg;G> ePh;frpjy; Mfpa 
FwpFzq;fs; cz;lhf;fp clk;gpd; ,aw;if epwj;ij  NtWgLj;Jk;. 
Neha; tUk; top (Aetiology) 
According to Yugi Vaithiya Chindamani, 
 “Vohd fug;ghdpd; cw;gj;jp Nfsha; 
  Vw;wkha; khkprq;fs; Grpf;ifahYk;> 
 $ohd fk;Gjpid tuF rhik   
  nghbjhd fpoq;Ftif aUe;jyhYk;> 
 ghohd ngz; khia jd;dpw; rpf;Fk; 
  ghq;fhd tpufj;jhy; Kaw;rpahYk; 
 jhohd gz;lq;fs; rikj;Jj; jpd;dy; 
  jhf;FNk fug;ghd; jd; rhay; jhNd 
 rhayha;j; jdf;Fj; jhd; %j;j ngz;izj; 
  jhtpNdhh; jho;r;rpahq;rhjp jd;dpy;  
 fhayha;f; fye;Jz;Nlhh; fyfk; nra;Njhh; 
  fw;Gila kq;ifaiuf; fUjpNdhh;fs;  
 thayha; tho; kuj;ij ntl;bNdhh;fs; 
  kUj;Jth;fs; tz;zhh; ehtpjh;fs; $ypf; 
 $ayha;f; nfhlh Njhh;fs; FUepe;jpj;j 
  nfhLk;ghtp fug;ghdpw; Fwpf; nfhs;thNu”  
- A+fp itj;jpa rpe;jhkzp  
(fug;ghd; Nuhf epjhdk;) 
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• Excessive intake of fish, meat, cereals like raagi, maize, and rhizomes.  
• Anti social activities which ultimately end in psychic disturbances leads 
to Karappan disease.  
According to Sirappu Maruthuvam, 
   “ngUFQ; Nrhs kpWq;Fk; ngUq;fk;G 
  tuF fhUld; thioapd; fhNahL 
    ciunfhs; ghfy; nfspw;W kPd; cz;bby; 
  tphpt jha;f;fug; ghDkp Fe;jNj” 
     -  rpj;j kUj;Jtk;  rpwg;G 
• This poem specifies the dietary relations with the karappan disease.  
• Bitter gourd, ragi, maize, unriped banana, fish items aggravates the disease. 
 
According to Guru Naadi Nool, 
 ‘rq;ifapy; tp\ fug;ghd; tUkhNwJ 
  rhuKld; fpUkp tpOe;jd;ikNaJ 
  cl;bzNk mjpfk; tUkpe;jphpa Nghfj;jh 
  YoWJUfp aj;jpapNyNtT nfhz;L 
  el;lzkha; nte;j njhU kr;ir jd;dpy; 
  ehl;lkpl;l fpUkpaJaZFk; NghJ 
  kl;LlNd fpUkpnay;yhk; gwe;jq;Nfwp 
  tifAlNd khq;fp\j;ijj; Jisj;J NkTk;” 
         jpl;lKld; tpl fug;ghd; gwe;J NkNy 
  jpdTlNd guguj;Jr; nrhwpAz;lhNk 
  gay;nkhopapu; Njfj;jpy; fpUkpjhNd 
  fufuj;Jr; nrhwp ngUFq; fug;ghd; jhNd”. 
 - FU ehb E}y; 
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Excessive Sexual indulgence aggravates Azhal thathu which inturn affects 
the “Kozhupphu” and “Thasai” of the seven udal kattugal. The micro organisms 
enter through these affected thathus and cause the disease Karappan. 
Neha; vz;(Classification) 
1) According to Yugi Vaithiya Chindamani: 
 Karappan is classified into seven types. 
            ‘Mnkd;w fug;ghd;jhd; VOtpjkhFk; 
  mlq;fhj thjj;jpd; fug;ghNdhL 
   fhnkd;w fz;lkhq; fug;ghdhFk; 
  fUfpa Njhh; twl;rpahq; fug;ghNdhL 
   Njnkd;w jpkph;thj fug;ghd; ehYk; 
  rpurpdpNy ngUq; fghyf; fug;ghd; 
   Nfhnkd;w gpj;jkhq; fug;ghNdhL 
  nghpa Nrl;Lkf; fug;ghd; ngah;jhNd” 
      - A+fp itj;jpa rpe;jhkzp 
1. thj  fug;ghd; 
2. gpj;j fug;ghd; 
3. fg fug;ghd; 
4. jpkph;thj fug;ghd; 
5. fz;l fug;ghd; 
6. fghyf; fug;ghd; 
7. twl;rp fug;ghd; 
        2) According to Agasthiyar Rana nool, the Karappan is classified into 
eighty types as follows, 
‘vz;gJ fug;ghd; jd;id apak;gpLkhW NfsPh; 
 ez;gpLk; thjk; gpj;jk; eyk;nfl;Lj;jhdk; tPq;Fk; 
  Gz;gLk; fuq;fs; re;J Giye;Jly; fLj;J NehFk; 
 td;ikAld; ntbj;J R+iy tUtJ uzkPnjd;Nd” 
- mfj;jpah; uz E}y; 
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3) According to Rathina Surruka Naadi Nool, there are eighty five varities of   
    Vatha Karappan.  
‘ehslh ehw;gJ ehY E}W 
  eaKlNd ehw;gj;J vl;LNuhFk; 
  ghug;gh thjkJ vz;gj;J ehY 
  gUf;fNt gpj;jkJ ehw;gj;J vl;L 
  jhug;gh Nrj;Jkq;fs;  njhz;Z}w;whW 
  gPypAlDW trpa kQ;rjhFk; 
  nghhpfug;ghd; njhd;D}W nfz;ilgj;J” 
               -  ,uj;jpd RUf;f ehb E}y; 
  4) As per Pathinen Siddhar Balavagadam, the Karappan affecting children is   
     classified into eighteen types.  
1. thj fug;ghd; 
2. gpj;j fug;ghd; 
3. fg fug;ghd; 
4. mhp fug;ghd; 
5. XL fug;ghd; 
6. R+iy fug;ghd; 
7. ntb fug;ghd; 
8. kz;ilf; fug;ghd; 
9. rl;ilf; fug;ghd; 
10. CJ fug;ghd; 
11. fUq;fug;ghd;  
12. nghhpfug;ghd; 
13. nfhs;sp fug;ghd; 
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14. Njhl fug;ghd; 
15. thiy fug;ghd; 
16. tws; fug;ghd; 
17. tPq;F fug;ghd; 
18. nrq; fug;ghd; 
 
fug;ghd; Nehapd; nghJf;FwpFzq;fs; 
(General Signs and Symptoms) 
           “ vz;gJ fug;ghd; jd;ikapak;gpL khW Nfsph; 
              ez;gpLk; thjk; eyk;nfl;Lj; jhdk; tPq;Fk; 
-------------------------------------------------------------------- 
              GifQ;rNkdp ypq;fj;jpw; Gz;NghY Uf;fpg; 
     ;        ------------------------------------------------------------------- 
              fisQ;RNk ePNuhL kyKq;rpf;Fk; frpANk fug;ghdhk;” 
                                                         -mfj;jpah; tpuzEhy; 
 
• Swelling all over the body.  
• Pain in the joints of the body. 
• Body temperature raises. 
• Appearances of papules, vesicles which burst leads to ulcer formation. 
• Oozing from the lesion. 
• Itching all over the body. 
• Scanty micturition and Constipation. 
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thj fug;ghd; FwpFzq;fs;: 
According to Yugi Vaithiya Chindamani, 
‘nfhs;sNt clk;ngy;yhk; ntJk;gha; nehe;J 
          File;JNk kpfr; Rue;J ;khFk;  
                 tps;sNt Njfnky;yhk; Gz;Nghy; nehe;J 
    ntbj;JNk Gz;zhFk; tpuy;fs; re;J 
                  Ks;sNt klq;fpNa euk;G fhZk; 
                    nkhopfs; gf;fkpf;f ,lkpf cyh;e;J 
                  ks;sNt NkdpaJ tuz;L fhZk; 
                   thjkhq; fug;ghd;wd; td;ikjhNd” 
                                 -A+fpKdp itj;jpa rpe;jhkzp 
  
• The body temperature rises. 
• The lesion starts as dry vesicles and later becomes exudative in nature 
leading to ulcers formation with secondary infection. 
• The lesion are highly Itching in nature. 
• Pain and swelling in the affected areas of flexures of upper and lower limbs 
(like wrist Knee, ankle joints, etc). 
• Difficultly in walking due to swelling in the joints.  
• The lesion show recurrence and come on and off.   
 
According to Pathinen Siddhar Balavagada Thiratu, 
‘njwpf;Fk; tPq;FKlnyq;F Nkjpkph; fLg;gjhfpaOe; NjfNkw; 
nghwpg;gwe;jnjdNt Gz;zhfpajpNy ntbj;jjpf nghq;fkha; 
  KWf;fpNa Rukjhfp ehtJ twz;L NehaJ Kjph;e;jpby; 
  ntwpf; fUq;Foyp khJthj fug;ghnddg; Gfy;th;Nktpl” 
       -gjpnzd; rpj;jh; ghythfl jpul;L 
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• Excessive body heat 
• pain and swelling all over the body 
• Appearances of vesicles, exudates  
• formation of ulcers 
• Difficultly to use affected limbs due to pain and swelling 
• Dryness of the body 
According to Agathiyar Vaagadam, 
  “jiyAq;fdj;J Fuy; nehpj;J jWfh Jlk;G jpkpUz;lh 
    AisAq; fhYk; tPf;fkhAisahjpUf;Fk; KWg;GisAk; 
  --------------------------------------------------------------------------- 
    aj;j Neha; thpNy thjfug;ghndd epidf;fyhNk” 
• Headache 
• Hoarseness of voice 
• Numbness 
• Swelling 
• Weakness 
• Pain and swelling in the joints 
  PINIYARIMURAIMAI: 
  The method adopted to find out a disease in Siddha system of medicine is 
termed as ‘piniyari muraimai’’. It is based on the following principles. 
  1. Poriyal arithal- These are the five sense organs. 
                      2. Pulanal theruthal- These are the functions of the sense organs.   
            3. Vinathal – Method of interrogation.  
The important method adapted by the Siddhars to diagnose the disease is by means 
of Envagai thervugal. 
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  ‘ehb ];ghprk; ehepwk; nkhop tpop 
   kyk; %j;jpukpit kUj;JtuhAjk;” 
           - Neha;ehly; Neha; Kjy; ehly; (1k; ghfk;)  
 Envagai thervugal is considered to be physician’s instrument and this can 
be understood by the above verse. Envagai thervugal constitute, 
1. Naadi 
2. Sparisam 
3. Naa 
4. Niram 
5. Mozhi 
6. Vizhi 
7. Malam 
           8.        Moothiram  
1. Naadi (Pulse) 
In the incidence of Karappan, the following naadi nadai were felt very 
commonly, 
1. Vatha kapham 
2. Kapha vatham 
3. Vatha Pitham 
 
2. Sparisam (Tactile sensation) 
 In the case of Vathakarappan, swelling, macule, vesicle, papule, itching, 
erythema, burning sensation, thickening, roughness of the skin, and pain were 
noticed. 
3. Naa (Tongue) 
No abnormalities are noticed. 
4. Niram (Colour) 
Redness and hyper pigmentation noticed in some cases. 
26 
 
5. Mozhi (Speech) 
No abnormalities noticed. 
6. Vizhi (Eye) 
Burning sensation of the eyes is noticed in some cases. 
7. Malam (Stools) 
 In some cases, constipation is noticed. 
8. Moothiram (Urine) 
               Collection of urine for the determination of neerkuri and neikuri is a 
special diagnostic method.        
                                'mUe;JkhwpujKk; mtpNuhjkha; 
   m‡fy; myh;jy; mfhyT+d; jtph;e;jow; 
   Fw;wstUe;jp cwq;fp itfiw 
   Mbf;fyrj; jhtpNa fhJnga; 
   njhU K$h;j;jf; fiyf;Fl;gl ePhpd; 
epwf;Fwp nea;f;Fwp epUkpj;jy; flNd” 
                                              Neha;ehly; Neha; Kjy; ehly; (1k; ghfk;) 
Neerkuri, 
                                 'te;jePh;f; fhpvil kzk; Eiu vQ;rnyd; 
           iwe;jpa Ysit aiwFJ KiwNa" 
Urine is examined for the following neerkuri: 
  epwk;        -  Colour  
  vil        -  Specific Gravity 
  kzk;     -  Smell 
  Eiu      -  Frothy nature 
 vQ;ry;   -  Quantity of urine voided 
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NEIKURI: 
                Neikuri is an important test to assess the predominantly affected 
humour.Early morning urine of the patient is collected in a glass container and 
examined within 1 ½ hrs. A drop of gingelly oil is dropped and kept in the sunlight 
at a calm place. The nature of the oil drop in the urine is noted. 
 If the oil drop, 
1. Spreads like a snake, it indicates vatha disease 
2. Spreads like a ring, it indicates pitha disease 
3. Appears like a pearl, it indicates kaba disease 
 
In Vathakarappan, the pearl like condition were seen, which is the character of the 
Kaba neer. 
gpw ghpNrhjid Kiwfs;: (Other Diagnostic Parameters)  
1. capHj;jhJf;fs;  
2. VO clw;fl;Lfs; 
3.  gUtfhyk; 
4. QhNde;jphpak; 
5. cly; td;ik 
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MUKKUTRAM 
Vatham- Vatham is the kinetic energy of all movements. 
Vatham Functions Affected 
Pranan Responsible for breathing and 
respiration 
 Affected. 
Abanan Responsible for passing urine, 
stools, sperms, menstrual 
flow,ova and foetus etc. 
Constipation, Burning or 
scanty micturition. 
Samanan For proper digestion Affected due to other vayus 
Viyanan Movements of all parts of the 
body 
Affected. 
Udhanan Responsible for vomiting, cough 
and nausea 
Not affected. 
Nagan Responsible for opening and 
closing of the eye 
Not affected 
Koorman Responsible for vision and 
yawning 
Not affected 
Kirukaran Responsible for salivation,nasal 
secretion and appetite 
Not affected 
Thevathathan Responsible for 
laziness,sleeping and anger 
Insomnia 
Dhanjeyan Produce bloating of a body after 
death. 
 Not affected 
 
In the case of Vatha Karappan, Pranan, Abanan, Samanan, Viyanan, and 
Dhevathathan are affected. 
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Pitham- Responsible for all transformation 
Pitham Functions Affected 
Anal pitham Gives appetite and helps 
digestion 
Indigestion, constipation, 
loss of appetite 
Ranjaga pitham Responsible for the colour 
of blood 
Eosinophilia, raised ESR, 
erythema, boil, ulcer, 
oozing,anemia 
Sathagam Controls the whole body Unable to do regular work 
properly due to intense 
itching 
Prasagam Gives complexion to skin Dryness, roughness, hyper 
pigmentation & 
lichenfication of the skin 
Alosagam For vision Not affected 
  
 In the case of Vatha Karappan, Anal Pitham, Ranjagam, Sathagam and 
Prasagam are affected. 
Kabham- Stabilizes, maintain and lubrication of all movements 
Kabam Functions Affected 
Avalambagam Controls all other 
forms of  kabam  
Affected due to other kabam affected 
Kilethagam For digestion Loss of appetite 
Pothagam Identifying taste Not affected 
Tharpagam Coolness of the eyes Not affected 
Santhigam Lubrication of the 
joints 
Pain in the joints 
  
 In the case if Vatha Karappan, Avalambagam, Kilethagam and Santhigam 
are affected. 
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Udal Thathukkal 
 There are seven udal thathukkal in human body. 
Saram 
 
Strengthens the body and mind 
 
Tiredness, roughness, dryness 
 
Senneer Preserves brightness, boldness 
Power and knowledge 
Tiredness, dryness, anaemia, 
erythema. 
Oon Gives structure and shape to body. 
Responsible for movement 
Erythema, vesicle, pustule, 
lichenification 
 
Kozhuppu Lubricate the organs and proceed on its 
own works 
Ulcer, boil. 
Enbu Protects vital organs and used for 
movements nominates body structure. 
Not Affected. 
Moolai It is present inside  the bones and gives 
strength and maintains the normal 
condition of the bone 
Not Affected. 
Sukkilam or 
Suronitham 
 
Meant for reproduction 
 
Not Affected. 
 
In the case of Vatha Karappan, Saaran, Senneer, Oon and Kozhupu are affected. 
Paruva kaalam (Season) 
In every season changes will occur in the land water, plants, animals, and 
human beings which will modify the physiology and makes them susceptible to 
certain diseases which are common in that season. 
Kabam gets thannilai valarchi in Pin pani kaalam and vetrunilai valarchi in 
Elavenil kaalam. Pitham sets Thannilai valarchi in Kaar kalam and vetru nilai 
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valarchi in Koothir kaalam. Vatham sets Thannilai valarchi in Mudhuvenil kaalam 
and vetrunilai valarchi in kaar kaalam. 
Gnanainthriyam 
Mei Touch sensation Roughness, heat & buring sensation 
Naa Analyse taste Not affected 
Kan For vision Not affected 
Mooku For smell Not affected 
Sevi For hearing Not affected 
 
Udal vanmai :( Body immunity) 
Iyarkai vanmai: Natural immunity of the body itself by birth. 
Seyarkai vanmai: Improving the health by intake of nutritious food materials, 
activities & medicines. 
Kaala vanmai: Development of immunity according to age and the environment. 
When udal vanmai is affected, there may be a possibility of Karappan. 
Kf;Fw;w NtWghLfs; 
 ‘kpfpDk; FiwapDk; Neha; nra;Ak; E}NyhH 
  tsp Kjyh vz;zpa %d;W” 
      - jpUf;Fws; 
             ];Jhy rhPuq;fshfpa rg;j jhJf;fSk; tsp> moy;> Iakhfpa 
Kf;Fw;wq;fSk; jj;jk; ,aw;if jd;ikapd;W NtWgLk; epiy Neha; 
vdg;gLk;. czT Kiw> gof;ftof;fq;fs;> kw;Wk; fhykhWghLfshy;> 
thjk;> gpj;jk;> fgk; %d;W jhJf;fSk; jd;dpiy gpwo;e;J> Nehia 
cz;lhf;FfpwJ.  
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thj fug;ghd; Nehapy; jd;tpid> gpwtpidfspd; gadhfj; J}z;lg;gl;l 
Iaf;Fw;wkhdJ> tsp moy; Mfpa Fw;wq;is Jiz nfhz;L Fwp 
Fzq;fis cz;lhf;FfpwJ. 
                               ‘thjkyhJ Nkdp nflhJ” 
         -Njiuah; 
 Nkw;$wpa Njiuahpd; $w;Wg;gb Njfj;jpd; xsp vd;Dk; moFk;> 
td;ikAk; nfLtjw;F Kf;fpakhd Kjw;fhuzk; tspf;Fw;wkhFk;. 
‘thAtpd; $W thjk;. thj Njhlk; td;ikailAk; NghJ fbdk;> twl;rp> 
,NyR> Fsph;r;rp> mirj;jy;> mZj;Jtk; Mfpa MW Fzq;fs; 
cz;lhfpd;wd. Nkw;$wpa Fzq;fs; Njhypy; fhzg;gLfpd;wd. 
 
The changes in the mukkutram form the basis of the pathology of a disease. 
The changes in the mukkutram may be either in terms of quantity increased or 
decreased kutram due to their quality, character, function, and type. 
In Vatha karappan, there is increase in the vatha kutram and kaba kutram. 
 
 Functions of Vatham: 
Body pain, redness and roughness of skin, tastelessness, sweating, sleep, 
constipation, oliguria, blackish discolouration of skin, urine, stool. 
If Increased: 
Weight loss, weakness, giddiness, constipation, insomnia, abdominal 
distension, blackish discolouration. 
If Decreased: 
Body pain, feeble voice, syncope, diminished 
 Functions of Kabam 
White complexion, dullness, itching, loss of sensation, heaviness, 
indigestion. 
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If increased: 
White complexion, loss of appetite, excessive salivation, diminished action, 
excessive sleep, cough, 
If decreased: 
         Giddiness, dryness of the joints, excessive sweating, palpitation, 
 
Udal thathu verupadugal: 
Udal thathu Increased features Decreased features 
Saaram Loss of appetite,  diminished 
activity, excessive salivation, 
sleep, cough. 
Dryness of the skin, loss of 
weight, tiredness, diminished 
activity. 
Senneer Boils in all parts, tumors, loss 
of appetite, jaundice, and 
splenomegaly. 
Tiredness, anemia, dryness. 
Oon Tumors around the neck, face, 
abdomen and thigh. 
Muscle wasting, tiredness. 
Kozhuppu Increased features of oon, and 
dyspnoea. 
Splenomegaly, weight loss. 
 
In Vatha karappan, the Saaram, Senneer, Oon and Kozhuppu are affected 
due to decreased features.  
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NOI KANIPPU VIVADHAM  
 gpj;j fug;ghd;  
‘jhdhff; fz;Jhq;fp eLT ce;jp 
                   jsh;e;JNk cl;fhhe;J ntJg;Gz;lhk; 
      Jhdhf; fpWfpWf;F KlyhQ; NrhUk; 
            nrhhpe;JNk clk;G kQ;rspf;Fk; 
       Ntzhf tz;zj;ij ,wq;nfhl;lhJ 
            kpLf;fhd jPgke; jpj;Jg; NghFk; 
                            Ngdhf CUtJ Nghyf; fhZk; 
                      gpj;j fug;ghd; Fzj;jpd; ntw;wpahNk” 
• Drowsiness. 
• Itching over the affected area. 
• Yellow discolouration of the skin. 
• Difficulty in swallowing. 
• Loss of appetite. 
• Lethargy and subjective vertigo. 
Nrj;Jkf; fug;ghd;  
‘ngw;wpaha;r; ruPukJ ntswpf; fhZk; 
              Ngr;Rj;jjhd; fk;kyha; jhdpUf;Fk; 
        Gjpjha; thh;j;ijaJ nghWf;fpr; nrhy;Yk; 
               gpugye;jhd; kpfg;Ngrp %r;Rz;lhFk; 
  vj;jpaha;r; rfyiuANkty; nfhs;Sk; 
           <isapUky; %r;Rf; fhjpiur;ry; 
                           Kj;jpaha; Nkhl;r top KiwahFk; 
                   Kjph; Nrl;gf; fug;ghdpd; %h;f;fe;jhNd” 
• Pale discoloration of the skin. 
• Hoarseness of voice, commanding others. 
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• Cough. 
• Tinnitus in the ear. 
fghy fug;ghd; : 
 ‘fhzNt fhnjy;yhk; jpdTz;lhFk; 
                fz; jpdthk; fz;le;jhd; fufuf;Fk; 
                           G+zNt fz;zpUk; gPisAz;lhk; 
         Ngr;Rke;j %f;fjdpy; ePNughAk; 
                           NjhzNt rpuRjdpw; nrhhpjYz;lhw; 
                Jk;ky; kpfTz;lhFe; Jbf;Fk; new;wp 
                           MzNt mz;zhf;fp oYz;lhFk; 
                   moq;fhj fghy fug;ghd;wd; FzkhNk” 
• Itching over the ear lobes and eye lids. 
• Excessive lacrimal secretion and plenorrhoea. 
• Running nose and sneezing. 
• Pain in the throat. 
• Itching over the head. 
fz;lf; fug;ghd;: 
‘jspuhfr; rpunkq;F kpff; fdj;Jj; 
                       jiyfhJ kz;inlay;yhe; jbj;J NehFk; 
  espuhf tUj;jp tpf;Fk; ehj;jbf;Fk; 
             eykhd clk;Gjdpw; nrhhpAkhFk; 
     Fspuhff; Fsph;e;JNk kaph;f;$r;rhFk; 
                  $g;gpl;lhy; kpfg;gafk; $Rq;fz;jhd; 
                            fspuhf Kl;Nghyf; fz;le;jd;dpy; 
             fufuf;Fk; fz;lkhq; fug;gdhNk” 
• Headache 
• Swelling and pain in the head and ear 
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• Hiccup and swollen tongue 
• Itching all over the body 
• Chillness with shivering 
• Glittering of vision 
• Roughness in the body 
twl;rpf; fug;ghd; 
   ‘;fz;lha; kpftPq;Fk; Fj;jYz;lhk; 
fdkhf clk;ngq;Fk; kpfNt CWk; 
      Jz;lkhAly; gijj;Jr; nrhwpjYz;lhFk; 
     NrhUNk nae;Neuk; kaf;fj;jhNy 
             tz;lfe;jhdpy;yhk Ylk;G tw;Wk; 
                khWghlha;g; gpjw;wp kWFk; thu;ij 
     gpz;lkhf;fp le;Jz;L GyhNy ehWk; 
                        ngUtwl;rp fug;ghd;wd; NghpjhNk” 
• Puffiness of face with deep seating pain. 
• Swelling and pain over the affected area. 
• Itching all over the body. 
• Disoriented words, Foul smell in the body. 
jpkph;thjf; fug;ghd; 
‘tz;ikah Al;fhh;e;J vOk;Gk; NghJ 
               tUj;jkha; fhy;iffsp ypLg;Gr; re;J 
   jpz;ikaha;j; jpkph;j;JNk fuL fl;Lk; 
                    nrayope;J tPq;fpa ntbj;Jg; Gz;zhFk; 
                           jd;ikaha; rlnkq;F KjyhFk; 
                        jz;zPh;jhd; kpfj;jlj;Jj; jdpr; #Lz;lhk; 
                           cz;ikaha; Nkdpnaq;Fk; cisr; rYz;lhk; 
         cjWNk jpkph;thjf; fug;ghDNk” 
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• Pain in the knee, elbow, wrist, hip, shoulder and fingers during sitting and 
standing. 
• Swelling of the joints which burst to form ulcers. 
• Pain all over the body, lethargy. 
Prognosis of  Karappan  (rhj;jpak;-mrhj;jpak;) 
           ‘%u;f;fkhk; rhj;jpaj;ij nkhopaf; Nfsha; 
nkhopfpd;w thj fug;ghd; wd;NdhL 
          Ch;f;fkha; gpj;j fug;ghDkhFk; 
              cah;fpd;w twl;rpahq; fghyf; fug;ghd; 
          ju;f;kh apJehYQ; rhj;jpakhk; 
   jSf;fhd jpkph;thjf; fug;ghd; fz;lk; 
          ePh;f;fkhQ; Nrl;g fug;ghd;wd; NdhL 
 nrg;gpaNjhh; ,J %d;Wk; mrhj;jpakhNk” 
                                          -A+fp itj;jpa rpe;jhkzp 
 
rhj;jpak;                                         mrhj;jpak; 
1. thj fug;ghd;                                 1.jpkph;thj fug;ghd; 
2. gpj;j fug;ghd;                                 2.fz;l fug;ghd; 
3. twl;rp fug;ghd;                              3.Nrj;Jk fug;ghd; 
4. fghy fug;ghd; 
kUj;Jt topKiw (Line of Treatment): 
 Apart from treating the disease with medicines, Siddhars have emphasized 
the two main parts of disease by prevention and improving the body condition.   
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This is stated as follows. 
 fhg;G   - (Prevention) 
 ePf;fk;  - (Treatment) 
 epiwT  - (Restoration) 
fhg;G (Prevention):   
Nehapdpd;W clypidf; fhf;f rpj;jh;fs; $wpa ehs; xOf;fk;> fhy 
xOf;fk;> gpzpaZfh tpjpfis filgpbf;f mwpTWj;j Ntz;Lk;. Nfhgk;> 
Jf;fk;> kd mOj;jk; ,tw;wpypUe;J tpLgl %r;Rg;gpapw;rp> Mrdq;fs; nra;a 
mwpTWj;j Ntz;Lk;. 
  thj> gpj;j> fg NjfpfSf;Fj; jf;fthW czTtiffis rhg;gpl  
mwpTWj;j Ntz;Lk;  
 NEEKAM (TREATMENT): 
1. To bring the three Dhosas in equilibrium initially Purgation is given 
2. Treatment of diseases by internal medicine & external applications 
3. Diet & Advices 
4. Yoga Therapy 
Since siddha system of medicine is based on the Mukkutra theory, the 
treatment is mainly aimed to bring down the three doshas to its equilibrium state 
and there by restoring the physiological condition by three thathus. 
Purgative:  
‘tpNurdj;jhy; thjk; jhOk;” 
So all the patients were advised to take 15 ml of vellai ennai with hot water 
(early morning) in empty stomach before treatment with trial drug. 
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Internal medicine: 
 Perumarapattai chooranam-1gm tds with water. 
 Reference: Agasthiyar 2000 third part Pg.no 73 
External medicine: 
 Pungu thylum externally 
 Reference: Yugi Muni Vaithiya Kaaviyam Pg.no 299 
Diet: 
 During the course of treatment, according to the drug administered to the 
patient and nature of the disease, the patients were advised to follow certain 
precautions regarding diet and physical activities.  This type of medical advice in 
siddha system of medicine is termed as ‘pathiyam’. 
• fug;ghd;  Nehapid  cz;lhf;ff; $bAkw;Wk;mjpfg;gLj;jf;$ba 
czT tiffshd nfhs;, ghfy>;  nfha;ah> Kl;il> fj;jhp 
khk;gok;> Gsp> cg;G> gaW tiffs;> mfj;jp fPiu> gPh;f;F> 
fhl;Lg;G+rzp ,tw;Wld; fk;G> tuF> fhuhprp> thiof;fha;> 
jbaq;fha; Mfpatw;iw ePf;f Ntz;Lk;. 
• vspjpy; rPuzpf;Fk; czT tiffis vLj;Jf; nfhs;sy; eyk;. 
kuf;fwp czT> ghy; kw;Wk; ghy; nghUs;fs;> rj;Js;s  czTfs; 
cl;nfhs;syhk;. krhyh nghUs;fs;;(Spicy Foods)kzg; nghUl;fs;> 
Nghijg; nghUl;fs;> fhug; nghUl;fs; ePf;f Ntz;Lk;. 
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PADMASANAM 
 
 
 
 
 
PUYANGASANAM 
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Yoga: 
Skin is the reflex of mind and so we should treat not only the physical but 
also treat the mind and soul. Thereby they were advised to do yoga practice i.e. 
Pranayamam, Asanas like pathamasana, Sarvangasana and Poorana Savasanthi 
Asanam. These asanas relive patient’s stress and strain and also cures the karappan 
disease. 
  Asanas or yogic exercise make the mind alert, improves concentration and 
help to maintain a buoyancy of spirit. They create a sound mind in a sound body-
V.G.Rele. 
 
gJkhrdk;: (gJkk; -jhkiu) 
rkjsj;jpy; rk;kzkpl;L cl;fhh;e;J tyg;ghjj;ij  ,lj;njhilkPJk; 
,lg;ghjj;ij tyj;njhil kPJk; Vw;wp ,uz;L iffisAk; Nfhh;j;J 
kyh;e;jpUf;FkhW ,Uj;jy; . 
gJkhrdk; nrhpkhd rf;jpAz;lhf;Fk;. cly; eyKk; kdkfpo;r;rpAk; 
Vw;gLj;Jk.;  Kf;Fw;wq;fSk; jd;dpiyg;gLk;. 
 
 
Gaq;fhrdk; (Gaq;fk; - ghk;G) 
fhy;fis ePl;b Fg;Gwg;gLj;J iffis Cd;wp jiy> khh;G> tapw;wpd; 
Nky;gFjp tiu NkNy J}f;fp itj;jpUj;jy;.  
Neha; vjph;g;G rf;jpia mjpfg;gLj;Jk;. 
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G+uz rt rhe;jpahrdk;  
ky;yhe;J gLj;J fhy;fis NeuhAk;> iffis clNyhL 
gf;fthl;bYk; itj;J Neuha;g; gLj;jpUj;jy;.  
,J fisg;ig Nghf;fp kdJf;F Gj;Jzh;r;rp cz;lhf;Fk;. 
- rpj;j kUj;Jtk; rpwg;G 
 
epiwT (Restoration): 
 The patients needs good discussion, motivation and persuasion to accept the 
eventually of the disease and prepare for life style that provides a disease free life.  
Preventive Methods: 
 Avoid allergic and dust atmosphere. 
 To find out which agent makes allergy and avoid them. 
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Modern Aspects 
Vatha karappan 
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MODERN ASPECTS 
SKIN ANATOMY 
The skin is the largest organ of the body. The skin and its appendages (hair, 
nails, sweat and oil glands) make up the integumentary system. Among its many 
functions the skin is an incredible organ always protecting the body from external 
agents. 
          Our skin is built up of two main layers. Within these two layers there are a 
range of different skin cells, sub-layers, nerves, blood vessels, sweat and oil 
glands, hair follicles, collagen and elastin fibres. The structure of the 3 layers of 
skin - the epidermis, dermis, and subcutaneous tissue. .  
Epidermis 
  The epidermis is the outer layer of skin. It is the thinnest on the eyelids at 
.05 mm and the thickest on the palms and soles at 1.5 mm. The entire epidermis is 
replaced by new cell growth over a period of about 48 days.  
The epidermis contains 5 layers. From bottom to top the layers are named,  
1. Stratum germinativum:   
• Deepest portion of the epidermis. . 
• Melanocytes are found in this layer.  
2. Stratum malpigii: 
• Superficial to the basal layer  
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3. Stratum granulosum: 
• Superficial to the stratum malphigii 
4. Stratum lucidum: 
• It is present only in the skin of the finger tips, palms and soles. 
  5. Stratum corneum (Corne-hard (or) hoof like) 
• This is the most superficial layer, thickest on palms and soles.. 
Dermis 
        The dermis also varies in thickness depending on the location of the skin. It is 
0.3 mm on the eyelid and 3.0 mm on the back. The types of tissue are:  
• collagen  
• elastic tissue  
• reticular fibers 
Layers of the Dermis 
     The two layers of the dermis are the papillary and reticular layers.  
• The upper, papillary layer. 
• The lower, reticular layer. 
Subcutaneous tissue 
         The subcutaneous tissue is a layer of fat and connective tissue that houses 
larger blood vessels and nerves. The size of this layer varies throughout the body 
and from person to person. 
Epidermal appendages like 
a. Pilosebaceous unit 
b. Sweat glands. 
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Pilosebaceous unit:  It consists of a hair follicle and sebaceous glands opening into 
follicular canal of hair follicle. 
Sebaceous gland:  
• Lipid secreting holocrine glands. 
• Distributed areas are scalp, face, and upper chest. 
• Activated under the influence of androgen hormone. 
 Sweat glands 
• Eccrine glands and apocrine glands 
 Eccrine glands 
• They are abundant on the palms, soles, forehead, and margin of lips, 
glans penis and axillae. 
• Over three million sweat units are present at birth. 
   Apocrine glands 
• Occur in the axilla, areola and nipples of breasts, umbilicus, around 
the anus and genitalia. 
• Their secretions are odoriferous with a secondary sexual 
significance. 
   Hair 
• Hair is found on almost every part of the body surface except on the 
palms, soles. Hair grows at the rate of 0.3 mm per day. 
   Nail 
• Nail is a continuously growing structure at a rate of 0.1mm per day. 
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PHYSIOLOGY 
Function Structure / cell involved 
Protection against chemicals, particles 
ultraviolet radiation antigens, haptens 
microbes 
Horny layer, melanocytes, langerhans cells, 
lymphocytes, mononuclear phagocytes, mast 
cells horny layer, langerhans cells, 
mononuclear phagocytes, mast cells. 
Preservation of a balanced internal 
environment: Prevent loss of water, 
electrolytes and macromolecules 
Horny layer 
Shock absorber Strong, yet elastic and 
complaint covering 
Dermis and subcutaneous fat  
Sensation Specialist nerve endings 
Calorie reserve Subcutaneous fat 
Vitamin D synthesis Keratinocytes 
Temperature regulation Blood vessels, eccrine sweat glands 
Lubrication and waterproofing Stratum corneum 
Protection and prising Nails 
Hormonal Testosterone synthesis from 
inactive precursors and testosterone 
conversion to other androgenic steroids 
Hair follicles, Sebaceous glands 
Body odour (more important in animals) Apocrine sweat glands 
Psychosocial 
Hair, nails, appearance and tactile quantity of 
skin. 
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ECZEMA- MODERN ASPECTS 
Definition 
Dermatitis and eczema is non contagious inflammation of the skin 
characterized by erythema, scaling, oedema, vesiculation and oozing. 
Eczema has been used as a descriptive term since the sixth century. 
Eczema is a Greek word (Ec-means “out”, zeo-means “boil”). The whole 
word implies “boil out”. 
Aetiology: 
Basically two factors causes dermatitis and eczema 
1) Firstly , an allergic or a sensitive skin 
2) Secondly, exposure to an irritant and some endogeneous substances. 
The general predisposing factors are,  
1. Age 
2. Familial predisposition 
3. Allergy 
4. Debility 
5. climate 
6. Psychological factors 
7. Xeroderma or Ichthyosis 
8. A greasy skin 
9. Hyperhidrosis 
10. Varicose vein causing congestion and focus of lowered resistance.  
11. Dysfunction of the intestinal tract 
12. Toxins and infection 
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The Aggravating factors can be summarized as follows 
1. Irritants  - Physical, Chemical or electrical  
2. Sensitizers  - Medicaments, Occupational hazards,  
plants, cosmetics and clothing.   
3. External infection- Streptococci, staphylococci, Fungus.  
4. Mental and emotional conflicts, strains and stresses.  
5. Internal septic focus shedding to or causing bacteraemia.  
6. Diet and stage of digestion. 
7. Diathesis   -  Allergic, Xerodermic, hyper- 
hydrotic (or) seborrhoeic.  
8. Drugs given for the disease (or) there wise. 
9. State of local (or) general nutrition. 
10. Climate - temperature and humidity. 
Some examples for Occupational hazards are as follows 
Agriculturists   - Plants, weeds, fertilizers 
Automobile    - Oil, petrol, solvent, grease, paints 
Building workers   - Cement, lime, paints, insecticides,  
wood, kerosene, turpentine oil 
Pharmaceutical industries  -  Dyes, Chemicals, explosives,  
Solvents, disinfectants, detergents 
Coal miners    - Mechanical injuries  
Dentists    - Cocaine and its derivaives 
Engineering industries  - Cutting oils, solvents 
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Housewives    - Soaps, detergents, vegetables,  
fruits, nickel, polishes, artificial flavours 
Nurses and Doctors   - Iodine, streptomycin, chlorpromazine,  
tincture, benzonin  
Photographers   - Hardeners, solvents, glass,  
cellulose esters 
Rubber workers   - Additives like TMT, MBT, dyes,  
glues, oils 
Tannery workers   - Chromate, formaldehyde, arsenic,  
alkalies, acids. 
Textile workers   - Formaldehyde, solvents, dyes. 
  
GENERAL SYMPTOMS 
• Redness of skin. 
• Itching is an essential symptom in diagnosing eczema but not a specific 
one. 
• Skin thickening of the affected area as compared to the unaffected region. 
• Blisters that emerge on the affected part. 
• Crusts – the secretions oozing from the inflamed region are rich in proteins. 
On drying they form a crust on the skin. 
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CLINICAL FEATURES: 
Acute eczema: 
Charecterised  by  intense  pruritic  papules  and  papulo  vesicles, erythema  
with  oozing  and  crusting. 
Sub acute:  
Charecterised  by scaling erythematous papules, with moderate erythema or 
oedema. 
Chronic:  
The above stages do not last long. In 2-3 weeks, the lesion starts to heal. If 
the cause persists, the eczema lasts for months or years and become chronic. In 
such cases, the skin becomes thickened and pigmented with lichenfication. 
The natural history of eczema is represented as follows 
HISTORY OF ECZEMA 
Erythema 
      
 Papules with oedema 
      
Vesicels      
 
        Weeping, crusting, pustules  Lichenification 
          
  Scaling 
    
       Healthy skin without scars  
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Immunology  
Immunology is a science which deals with the body’s response to antigenic 
challenge. This mechanism is involved in the protection of the body against 
infectious agents but periodically they can also cause damage. 
Sensitization develops when a different clone of T-lymphocytes is 
activated. The sensitized T-lymphocytes yield two sub populations of 
lymphocytes. 
1. Memory cells that is responsible for the persistence of contact allergy. 
2. Effector cells that initiate the allergic response when appropriately 
challenged. 
Reaction time: 
It is the time taken by a sensitized individual to manifest a clinical reaction 
following contact with a known sensitizer. 
It is usually 12-24 hours but may vary from one hour to 120 hours. 
Dissemination reaction: 
It is a fleeting erythematous macular reaction involving the face and 
flexures, caused by the escape of lymphokines in the circulation resulting in 
vasodilatation at distant site.  
Flare reaction:  
Flare reaction is reactivation of a previously healed site of a contact 
dermatitis or a positive patch test reaction following renewed challenge or 
exposure to the same allergen at another site. This is because of persistence of 
sensitized lymphocytes at the site of earlier reaction, which react to minute 
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amounts of antigen sometimes, escape in the circulation form the new site and find 
its way to the old site. 
 
PATHO PHYSIOLOGY 
Allergy & hypersensitivity: 
 Both terms are synonyms. 
 The concept of hypersensitivity was first introduced by Portier and Richet. 
 The term allergy was first used by Von Pirquit (1874 - 1929) to denote 
changed reactivity of the body to outside chemicals. 
Changed reactivity in this context means that the body behaves in a 
particular way when it is exposed to a chemical substance known as ‘Allergen’ for 
this first time, but changes the nature of its reaction when it is exposed for the 
second and subsequent times. This change is due to proteins known as antibodies. 
The moment, the allergen IgE combination stimulates the mast cells which 
unload their chemical contents into the surrounding tissues. These chemicals 
(mediators of allergy) cause the manifestations of allergy such as erythema, wheal 
and flare reaction. Flare is due to dilatation of arterioles by local axon reflex and 
the liberation of vasodilator substances like histamine and it’s by products like 
serotonin, bradykinin, acetylcholine from the injured cells like mast cells and 
basophils etc. The manifestation of hypersensitivity may be immediate (or) 
delayed type. 
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Cutaneous Allergy 
In the skin there are two important but different allergic reactions occur. 
Dermal reaction: 
• Dermal reaction is commonly seen in urticaria.   
• The causuative antigen reaches the skin through ingestion, inhalation or 
injection of protein substances and the reacting antibodies circulate in the 
serum. 
• Allergic reaction takes place in the dermis 
• Intra dermal tests (scratch) shows reactivity 
Epidermal reaction: 
• It is seen in allergic dermatitis or eczema. 
• The causative substance reach the skin by contact, Intra dermal allergic 
tests are negative. 
• But patch test shows reactivity 
• Allergen + Epidermal protein – Antigen formation (probably in lymph 
glands) 
• Circulation  - Fixed in epidermal cells on next occasion 
• Allergen + Antibodies – Eczematous reaction (In epidermis) 
• A severe local reaction may result in auto-intoxication & dissemination of 
eczematous reaction to distant parts. 
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Status Eczematicus 
It is believed that in case of severe allergic states, a state may develop when 
the patient becomes hypersensitive to even unrelated substances resulting in status 
eczematicus comparable to status asthmaticus in practice of internal medicine. 
Further it must be realized that Dermal or epidermal sensitization affects the 
entire integument and this sensitization once acquired is life – long. According to 
some, a degree of bloating in reactivity may be seen with the passage of time.                                                                                 
HISTOLOPATHOLOGY: 
 Formation of intercellular oedema (spongiosis) and vesicle formation. 
 In chronic cases, hyperkeratosis, acanthosis, and infiltration of upper dermis 
with lymphocytes seen. 
CLASSIFICATION 
There are two groups of eczema. 
Exogenous Endogenous 
Irritant Atopic 
Allergic Seborrhoeic 
Photodermatitis Discoid 
 Asteatotic 
 Gravitational 
 Neurodermatitis 
 Infectious  eczymatoid   
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EXOGENEOUS ECZEMA:  
Contact dermatitis: 
Contact dermatitis is inflammation of the skin (rash) that may result when 
the skin is touched by chemicals or physical substances that cause an allergic or 
irritant reaction. 
There are three types of contact dermatitis are,  
1. Allergic contact dermatitis -- occurs when skin, which has become sensitized to 
a certain substance (allergens). This is a delayed skin reaction that typically 
develops 12 to 72 hours after exposure.  
2. Irritant contact dermatitis -- occurs when the skin is exposed to a mild irritant 
(such as detergent or solvents) repeatedly or a strong irritant (such as acid, alkali, 
solvent, strong soap or detergent). 
3. Photo contact dermatitis--PCD is the eczematous condition which is triggered 
by an interaction unharmful or less harmful substance on the skin and ultraviolet 
light (320-400 nm UVA). 
Contact dermatitis symptoms can range from mild redness and dryness to 
severe pain and peeling that can be disabling, reddening of skin (either in patches 
or all over the body), intermittent dry, scaly patches of skin, blisters that ooze, 
burning or itching that is usually intense without visible skin sores (lesions), 
swelling in the eyes, face, and genital areas (severe cases) , hives, Sun sensitivity , 
darkened, "leathery," and cracked skin.  
 
60 
 
Endogeneous eczema: 
Atopic eczema:  
Atopic dermatitis is an inflammatory chronically relapsing, non-contagious 
and pruritic skin disorder. The causes of the atopic eczema may be emotional- 
psychiatric, environment, allergic- Food, external contacts and inhalants, 
epidermal barrier system and histamine intolerance. Atopic dermatitis often occurs 
together with other atopic diseases like hay fever, asthma and allergic 
conjunctivitis.Hand and feet, and on the ankle, wrist, neck and upper chest are the 
common sites involved.  
         Atopic dermatitis is also known as infantile eczema, when it occurs in 
infants. Infantile eczema may continue into childhood and adolescence and it often 
involves an oozing, crusting rash mainly on the scalp and face, although it can 
occur anywhere on the body. The appearance of the rash tends to modify, 
becoming dryer in childhood and then scaly or thickened in adolescence while the 
itching is persistent. Red, inflamed, and itchy rash and develop into raised and 
painful bumps are the main clinical symptoms found. 
          Diagnostic criteria of atopic eczema includes  Pruritus, Xerosis, History of 
asthma/ hay fever, Flexural folds, Early age of onset and Elevated serum IgE level. 
Seborrhoeic Eczema: 
This condition which is characterised by a red scaly rash affects the scalp 
(dandruff) central face, nasolabial folds, eyebrows and central chest. 
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            It affects infants and adults and associated with increased sebum 
production of the scalp and sebaceous follicle. The main Causative factors are 
Genetic factors and hormonal factors  
Nummular eczema (Discoid eczema): 
         Nummular (meaning "coin-shaped") dermatitis is characterized by prurtic, 
round-to-oval erythematous plaques found on the arms and legs, bilaterally 
symmetrical, worsen at night. Secondary infection (Staphylococcus aureus) may 
result in lesions that ooze serosanguineous exudate. 
       Lesions are often symmetrically distributed. The etiology is unknown and 
likely multifactorial.  
Pompholyx (Dyshydrosis) 
      Pompholyx itchy is characterized by deep seated vesiculation on the palms and 
sides of the fingers and soles of the foot with bilaterally symmetrical. Provoking 
factors are heat, stress and nickel ingestion. 
Aseatotic eczema (winter cczema): 
          This is seen in elderly and those with atopic dermatitis or ichthyosis 
vulgaris. Lesion in limbs and trunks with erythematous, dry and itchy (Crazy 
paving pattern of fissuring) are seen. 
Stasis Eczema: 
           It Occurs as a result of venous stasis on the lower portion of the legs. 
Eruption is brownish black pigmentation and secondary infection leads to 
ulceration and atrophic scarring. The cause is mainly due to perivascular fibrin 
deposition and abnormal small – vessel vaso constrictive reflexes. 
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Lichen simplex chronicus (Neurodermatitis) 
         Lichen simplex chronicus is charecterised by lichenified plaque lesion or 
lesions due to repeated rubbing or scratching or due to stress.it is common among 
young people and menopausal women.the  Clinical features are  the skin become 
thickened, infiltrated and pigmented with irregular margin.the Common Sites 
involved are ankles and wrists nape of the neck, genitalia (Scrotum or mons 
pubis). 
 
Infectious eczematoid dermatitis: 
This results from sensitization to certain organisms like streptococci, 
staphylococci, dermatophytes and yeast organisms.the common  Sites are Body 
folds, and hair follicles.the Clinical features are Well defined margin, Erythema, 
vesiculation, profuse exudates, crusting, creasy, Moist scales are appeared, Small 
pustules at the advancing edge and Pruritis present. 
INVESTIGATION: 
Investigation of Eczema 
Patch test 
Patch test  detect type IV (delayed or cell-mediated) hypersensitivity. 
The sites are then examined for a positive reaction 24 hours later and 
possibly again a further 24 hours later. The positive test is revealed by the 
development of an eczematous patch with erythema swelling and vesicles at the 
site of application. 
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Patch test reaction is graded in the following degrees 
  + - Only redness 
  ++ - Marked redness and swelling 
  +++ - Marked redness, swelling and papules 
  ++++ - redness, oedema and vesicles 
Specific IgE 
Specific IgE levels to antigens can be measured in serum by a specific radio 
allergic sorbent test (RAST). 
These are occasionally performed to support diagnosis of atopic eczema and 
to determine specific environmental allergens, eg. pet dander, horse hair, house 
dust mite, pollens and foods.   
Prick test 
Prick test are a way of detecting cutaneous type I (immediate) 
hypersensitivity to various antigens such as pollen, house dust, mite or dander. 
Bacterial and viral swabs for microscopy and culture 
These are useful tests in suspected secondary infection skin swabs for 
bacteriological assessment will invariably reveal the presence of bacteria.  In the 
case of recurrent impetigo in a child with atopic eczema, bacterial swabs should be 
taken from carrier sites (axilla and groin) from both the affected individual and 
house hold members. 
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Hints of diagnosis for all eczemas 
1. Nature of the lesions- size, shape, itching, number of papules, pustules, 
erythema etc. 
2. Distribution – sites of lesion. 
3. History of occupation. 
4. History of exposure to allergens – i.e. Chemicals, plants, soap, etc., 
5. Personal and family History of such diseases – e.g atopic or allergic  
                                                                                                           eczemas. 
6. Climate – eg:  Dyshidrosis occurs at the change of seasons particularly in 
   spring, summer. 
7. Patch tests (allergy test) in allergic/ atopic eczemas. 
 8. Biopsy in rare cases when the lesions do not respond to treatment. 
 
General lines of managements 
1. Explanation and reassuring the patient.  
2. Psychotherapy – counseling and antidepressants mild sedatives learn 
to live with it, anger, frustration avoided. 
3. Correcting or eliminating the etiological factors. 
4.     Exposure to sunlight or extremes of climate to be avoided, change of 
place or A/C advised. 
5. Scratching and rubbing to be avoided, the nails to be cut short. 
6. The health of the patients is improved by multivitamins, iron, protein. 
7. Be aware of any foods that may cause an outbreak and avoid those 
foods 
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8. Avoid harsh soaps, detergents, and solvents 
9. Avoid environmental factors that trigger allergies pollens, molds, 
mites, and animal dander. 
10. Protection of the affected part with cotton bandage, glove and mask. 
11. Rest 
12. Protect the skin from irritants. 
13. Reduce stress with relaxation techniques. 
Differential diagnosis: 
Psoriasis: Patches of erythema with silvery, typical distribution, little                                                                                                                                                                                                                                                                                       
oozing, pin point bleeding and scaling. 
Pitriasis rosea: Herald patch, medallion like lesions on back with pointing towards    
the centre, distribution along the ribs. 
Tinea corporis: Well-defined macules, inflammatory border and central clearing, 
marked central clearing, marked itching.          
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Materials and Methods 
       Vatha karappan 
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MATERIALS AND METHODS 
 The study on clinical evaluation of the disease Vatha Karappan was carried 
out in the Post-Graduate Sirappu Maruthuvam department at Government Siddha 
Medical College, Palayamkottai. Twenty patients were selected for the study and 
admitted in the post-graduate Sirappu Maruthuvam ward. After discharge of these 
in-patients, all of them were followed as out-patients in the outpatient department. 
Selection of Patients: 
 For this clinical study, 40 cases were selected from both sexes of varying 
age groups. All the cases were carefully examined before admission for correct 
diagnosis and rule out any other co-existing illness. 
Study of Siddha clinical diagnosis: 
 The author prepared a case sheet on the basis of Siddha methodology (ie) 
poriyal arithal, pulanal theruthal, vinathal, envagai thervugal, ezhu udarkattugal, 
thinai, paruva kaalam and modern methodology to diagnose the disease. The 
individual case sheet was maintained for each and every patient. 
Evaluation of clinical parameters: 
      During admission, the detailed clinical history was taken from the patients. 
The cardinal signs and symptoms of eczema like itching, vesicles, oozing, pain, 
oedema, crusting scaling and ulcers were also taken as criteria for the Vatha 
karappan cases. A detailed clinical history was taken by regarding the history of 
present and past illness, family history, aggravating factors, occupation, socio-
economic status, dietary and personal habits and associated history such as 
bronchial asthma and hay fever. 
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Clinical Investigations: 
 The modern diagnostic investigations such as Blood tests for TC, DC, ESR, 
HB, sugar, urea, serum cholesterol, urine analysis for sugar, albumin deposits and 
skin scrapping tests for fungus, stool examination, cyst to rule out any systemic 
illness.  
 Efficacy of the trial drugs was found by biochemical analysis, carried out in 
the Department of the Bio-Chemistry, Government Siddha Medical College, 
Palayamkottai. 
 Pharmacological analysis of the trial drug was carried out in the 
Department of Pharmacology, Government Siddha Medical College, 
Palayamkottai.  
Management: 
 “Viresanathal vatham thazhum” as per the Siddha aspect of this world, the 
author has selected the drug name Vellai ennai which is one among the purgatives 
in Siddha system. 
 All the patients were advised to take 10 ml of vellai ennai with hot water 
early morning in empty stomach before treated with trial drug. 
Trial drugs 
• Perumarapattai Chooranam-1gm 3 times a day with honey or water. 
• Pungu thylam- Applied externally over the affected areas. 
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OBSERVATIONS AND RESULTS 
Results were observed with respect to the following 
• Sex Reference 
• Age Reference 
• Kaalam distribution (life span) 
• Occupational status 
• Socio economic status 
• Diet reference 
• Seasonal Reference 
• Thinai Reference 
• Gunam Reference(Characteres) 
• Mode of Onset 
• Aetiological reference 
• Clinical reference 
• Associated history 
• Incidence of upper and lower limbs 
• Duration of the illness 
• Distribution of Uyir Thathukual 
• Ezhu (Seven) udar Kattugal reference 
• Envagai thervugal 
• Neerkuri and Neikuri reference 
• Results after treatment 
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Table 1 
SEX REFERENCE 
 S. No. Sex No. of Cases Percentage 
1. 
2. 
Male 
Female 
 
26 
14 
65 
             35 
 
 
 Out of total 40 patients, who were taking medicine in OP and admitted in 
the hospital for the trial, 26 were males (65%) and 14 were females (35%). 
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Table 2 
AGE REFERENCE 
Out of 40 cases selected for clinical trial, most of them were age above  50. 
S.No. Age No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
 
10-20 
21-30 
31-40 
41-50 
51-60 
61-70 
71-80 
 
- 
2 
2 
4 
11 
12 
9 
 
- 
5 
5 
10 
27.5 
30 
22.5 
 
 
        
  
AGE REFERENCE 
   
        
 
 
       
        
        
        
        
        
        
        
        
        
        
        
        
        
        
         
 
 
 
0
5
10
15
20
25
30
0
5 5
10
27.5
30
22.5
10 to 20
21 to 30
31 to 40
41 to 50
51 to 60
61 to 70
71 to 80
73 
 
Table 3 
KAALAM DISTRIBUTION 
 Different age groups were treated out of 40 the cases, most of them were in the 
Pitha kaalam, next in the Kaba kaalam but very less in Vatha kaalam. 
 S. No. Kaalam No. of Cases Percentage 
1. 
2. 
3. 
 Vatha kaalam(0-33) 
 Pitha kaalam(34-66) 
       Kaba kaalam(67-100) 
          4 
         30 
          6 
            10 
            75 
            15 
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Table 4 
                                    OCCUPATIONAL STATUS 
 Occupational history is closely associated with Vatha karappan disease. 
Detailed history about the nature of the work has interrogated and illustrated as 
follows. 
 S. No.    Nature of status No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
     6. 
     7. 
Farmers 
Coolies 
General merchant 
House wives 
Student 
Painter 
Tailor 
16 
14 
2 
4 
2 
1 
1 
40 
35 
5 
10 
5 
2.5 
2.5 
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Table 5 
SOCIO ECONOMIC STATUS 
 The incidence of the disease was found to be higher in lower economic 
groups. 
 S. No.  Socio economic status No. of Cases Percentage 
1. 
2. 
3. 
       Poor 
            Middle 
            Rich 
 
          32 
           8 
          - 
            80 
            15 
            - 
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Table 6 
DIET REFERENCE 
 Cases were enquired of their dietary habits, it was noted that 87.5% cases 
were non-vegetarian and 12.5 % were vegetarian. 
S.No. Food Habit No. of cases Percentage 
1. 
2. 
Vegetarian 
Mixed diet 
5 
35 
         12.5 
87.5 
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Table 7 
SEASONAL REFERENCE 
 When these 40 cases were enquired with that of the seasonal link, with 
occurrence and severity of this disease, it mostly occurred in Munpani kaalam, 
Pinpani kaalam, Elavenil kaalam, and Mudhuvenil kaalam. 
S.No. Paruvakaalam No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
   Kaar kaalam 
   Koothir kaalam 
 Munpani kaalam 
   Pinpani kaalam 
   Elavenil kaalam 
Muthuvenil 
- 
- 
8 
18 
6 
8 
- 
- 
20 
45 
15 
20 
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Table 8 
THINAI REFERENCE 
Out of the 40 cases, 37 cases are from Marutham (92.5%) and 3 cases from Neithal 
(7.5%). 
S.No.    Type of lands No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
Kurinji 
Mullai 
Marutham 
Neithal 
Palai 
- 
- 
37 
3 
- 
- 
- 
92.5 
7.5 
- 
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 Table 9 
 GUNAM REFERENCE 
 Out of 40 cases 80% had Rajo gunam and 20% cases had Thamo gunam 
respectively. 
S.No. Type of gunam No. of cases Percentage 
     1. 
2. 
3. 
Sathuva gunam 
  Rajo gunam 
 Thamo gunam 
           
              - 
             32 
               8 
 
         
          -   
         80 
         20 
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Table 10 
MODE OF ONSET 
Out of 40 cases of clinical trials were 70% were found to be chronic sufferers. 
S.No. Mode of onset No. of cases Percentage 
1. 
2. 
3. 
Acute 
       Sub acute 
       Chronic 
6 
6 
28 
         
        15 
        15  
        70 
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Table 11 
AETIOLOGY 
      When the 40 cases taken for the study were observed were due to occupational 
status, poor hygiene, incompatible diet, anxiety, family history, insect bite and 
irritants or allergens. 
S.No. Aetiology No. of cases Percentage 
            1 Occupational status        19          47.5 
            2 Incompatible diet          3          7.5 
            3 Positive family history          3          7.5 
            4 Insect bite          5         12.5 
            5 Irritants or allergens          8          20 
            6 Psychological stress          2           5 
 
 
 
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
40.00%
45.00%
50.00% 47.50%
7.50% 7.50%
12.50%
20%
5%
AETIOLOGY
Occupational status
Incompatible diet
Positive family history
Insect bite
Irritants or allergens
Psychological stress
82 
 
                           Table 12 
CLINICAL FEATURES 
Regarding the signs and symptoms 
SI.NO Clinical features No. of cases Percentage 
1 Erythema 7 17.5 
2 Itching 40 100 
3 Vesicles 34 85 
4 Oedema    11 27.5 
5 Pustules 2 5 
6 Oozing 34 85 
7 Pain 15 37.5 
8 Ulcers 4 10 
9 Lichenification 6 15 
10 Constipation 10 25 
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Table 13 
ASSOCIATED HISTORY 
Vatha karappan is commonly an immunological disorder for all ages, other 
associated conditions such as bronchial asthma, urticaria were noted in some cases. 
S.No. History No.of Cases  Percentage 
1 Bronchial asthma            6           15 
2 Hay fever             -             - 
3 Urticaria           10           25 
4 Diabetes             2            5 
5 Family History             8            8 
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Table 14 
                      INCIDENCE OF UPPER AND LOWER LIMBS 
S.No. Site of lesion No. of Cases Percentage 
1. 
2. 
3. 
 
Upper Limbs 
Lower Limbs 
Both upper and Lower limb 
 
36 
2 
2 
 
90 
5 
5 
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Table 15 
                                 DURATION OF THE ILLNESS 
S.No. Duration of the illness No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
 
1-3 months 
3-6 months 
6months-1year 
1-2 years 
More than 2 years 
 
16 
14 
7 
7 
5 
 
 
40 
35 
17.5 
17.5 
12.5 
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DISTRIBUTION OF UYIR THATHUKKAL 
Table 16 
DERANGEMENT OF VATHAM 
S.No. Classification of Vatham No. of cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
Piranan 
Abanan 
Viyanan 
Udhanan 
Samanan 
Nagan 
Koorman 
Kirukaran 
Thevathathan 
Dhananjeyan 
6 
10 
40 
- 
40 
- 
- 
- 
7 
- 
15 
25 
100 
- 
100 
- 
- 
- 
17.5 
- 
 
 In Dasa Vayu, Viyanan in 40 patients (100%), Samanan in 40 patients 
(100%), Pranan in 6 patients (15%), Thevethathan in 7 patients (17.5%). 
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DERANGEMENT OF PITHAM  
S.No. Classification of pitham No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
Analaga pitham 
Ranjaga Pitham 
Sathaga pitham 
Alosaga pitham 
Prasaga pitham 
3 
7 
11 
- 
40 
7.5 
17.5 
          27.5 
- 
100 
 
 
In Pitham, Prasagam were affected in 40 patients (100%), Analaga pitham 
were affected in 3 patients (7.5%) and Ranjaga pitham were affected in 7 patients 
(17.5%) . 
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DERANGEMENT OF KABAM 
S.No. Classification of Kabam No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
Avalambagam 
Kletham 
Pothagam 
Tharpagam 
Santhigam 
6 
- 
- 
- 
10 
15 
- 
- 
- 
25 
 
In Kabam, Avalambagam (15%) and Santhegam (25%) were affected 
Pothagam, Tharpagam, Santhigam was not affected.   
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Table 17 
UDAL KATTUGAL REFERENCE 
S.No. Udal Kattugal No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Saaram 
Senneer 
Oon 
Kozhupu 
Enbu 
Moolai 
Sukilam/ Suronitham 
40 
40 
40 
4 
- 
- 
- 
100 
100 
100 
10 
- 
- 
- 
 
All 40 patients were affected saaram and senneer, and oon (100%) and 
kozhupu in 10% cases are noticed. Other udal kattugal were not affected.  
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Table 18 
ENVAGAI THERVUGAL 
S.No. Envagai Thervugal No. of Cases Percentage 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
Naadi 
Sparisam 
Naa 
Niram 
Mozhi 
Vizhi 
Malam 
Moothiram 
40 
40 
2 
40 
- 
- 
10 
- 
100 
100 
5 
100 
- 
- 
25 
- 
 
 Naadi and niram, sparisam were affected all of the 40 patients (100%), Naa 
were affected in 2 patients (5%), Malam were affected in 10 patients (20%). 
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Table 19 
NEERKURI AND NEIKURI REFERENCE 
S.No. Type of Test No.of Cases Percentage 
1 Neerkuri 
Vaikol niram 
         
40 
 
100 
2 Neikuri 
Spreading like snake 
Spreading like ring 
Standing like a Pearl 
 
30 
- 
10 
 
75 
- 
25 
 
According to Neikuri in 75% cases it spreads like a snake, in 25% cases it 
stand like a pearl. 
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Table 20 
RESULTS AFTER TREATMENT 
S.No Results No. of Cases Percentage 
1. 
2. 
3. 
 
Good relief 
Moderate relief 
Mild relief 
 
29 
11 
- 
 
72.5 
27.5 
- 
 
 
Out of 40 patients, 11 patients got moderate relief, 29 patients got good 
relief. 
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CASE SUMMARY OF IN-PATIENTS 
 
 
 
 
 
 
 
 
 
 
S.NO 
IP.N
O 
NAME 
AGE/ 
SEX 
D.O.A D.O.D 
NO OF 
DAYS 
TREA
TED 
TREATMENT RESULT 
1. 1549 Mukayya 80/M 18.07.11 09.08.11 22  
 
Perumarapattai 
chooranam 1gm 
3 times a day 
with water. 
Pungu 
thylum(External) 
MR 
2. 1865 Susai rathnam 64/M 16.08.11 17.09.11 31 GR 
3. 2261 Balraj 63/M 23.09.11 3.10.11 11 GR 
4. 2290 Indra 65/F 26.09.11 14.10.11 19 GR 
5. 2883 Annamalai 47/M 8.11.11 
OP 
followup 
 GR 
6. 2755 Veyyilmuthu 51/F 3.11.11 30.11.11 28 MR 
7. 3113 Alaghupandiyan 60/M 2.11.11 10.11.11 9 GR 
8. 3110 Poyilammal 65/F 1.12.11 21.11.11 21 GR 
9. 3211 Alaghuraja 58/M 12.12.11 26.12.11 15 GR 
 
10
. 
3238 Muthayya 70/M 25.12.11 8.1.12 16 MR 
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CASE SUMMARY OF OUT-PATIENTS 
SNO OP.NO NAME 
AGE/
SEX 
COMPLAINTS 
NO OF 
DAYS 
TREA
TED 
RESULT 
1 46654 Rajam 51/F Itching,Lichenified,vesicles 45     GR 
2 45168 Subramanian 50/F Itching,vesicles,oozing 30     GR    
3   41510 Laaser  57/M Itching,erythema,vesicles 25     MR 
4   40831 Jesuraj  40/M Itching,erythema,vesicles,oozing 50     GR 
5 41899 Gopinath  19/M Itching,vesicles, oozing 21     GR 
6 40453 Karunakaran  60/M Itching,lichenfication. 14     MR 
7 48096 Mariamma 43/F Itching,vesicles,oozing 29     GR 
8 43835 Kannan  55/M Itching,vesicles,oozing 21     MR 
9 45112 Mukkaya  50/M Itching,vesicles,oozing,oedema 45     GR 
10 40594 Subbulashmi 56/F Itching,vesicles,oozing 21     GR 
11 52206 Perumal  65/M Itching,vesicles,oozing 25     GR 
12 45115 Vellayan  55/M Itching,vesicles,oozing 14     MR 
13 47767 Muniaswamy  57/M Itching,erythema,vesicles 21     MR 
14 43097 Mani  37/M Itching,erythema,vesicles 34     GR 
15 47462 Lakshmi 50/F Itching,lichenification,vesicles 40     GR 
16 45168 Subramanian  58/M Itching,vesicles,oozing 38     GR 
17 57825 Pudhiyavan  60/M Itching,vesicles,oozing 21     GR 
18 42109 Shanmugavel  70/M Itching,lichenification,vesicles 27     GR 
19 50906 Muthaya  67/M Itching,pustules,vesicles 45     GR 
20 52307 Muthulashmi 53/F Itching,lichenfication,vesicles,oozing 40     GR 
21 48609 Gandhimathy 50/F Itching,vesicles,oozing 22     MR 
22 51310 Ilavarasi 23/F Itching,vesicles,oozing 14     MR 
23 52462 Sellaya 50/M Itching,erythema,vesicles 19     MR 
24 54236 Muniappapillai  60/M Itching,vesicles,oozing 27     GR 
25 48407 Muthayya 52/M Itching,lichenfication,vesicles 38     GR 
26 58623 Veeradurairaj 47/M Itching,lichenfication,vesicles 45     GR 
27 55896 Periaswamy 45/M Itching,vesicles,oozing 30     GR 
28 65513 Janakiraman 22/M Itching,vesicles,oozing 28     GR 
29 52983 Indra  65/F Itching,vesicles,oozing 35     GR 
30 65550 Eswaran 65/M Itching,erythema,vesicles 25     MR 
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                                                          TABLE SHOWS LABORATORY INVESTIGATION REPORT OF IN PATIENTS AND OUT PATIENTS 
          
                                  
S. 
0P. NO 
& IP 
NO 
TC 
DC ESR   
Skin 
Scrapping 
for fungus Urine Analysis Motion Analysis 
NO P L E HB % BT AT BT AT 
BT AT 
BT AT BT AT 
  
BT AT BT AT BT AT BT AT BT AT 1/2 
hr 1 hr 
1/2 
hr 
1 
hr 
BS BU SC BS BU SC Alb Sug Dep Alb Sug Dep Ova Cyst Ova Cyst 
1 1549 8800 9000 72 
74 
24 26 4 2 10 12 5 10 3 8 185 46 116 120 30 110 -ve -ve NIL NIL 3-4 NIL NIL 1-2 NIL NIL NIL NIL 
2 1865 8500 8600 65 
66 
31 35 4 2 11 11.1 10 22 7 15 68 28 218 70 28 210 -ve -ve NIL NIL 2-3 NIL NIL 1-2 NIL NIL NIL NIL 
3 2267 12700 8500 74 
54 
20 24 6 2 8.5 9.5 13 57 10 22 98 20 200 87 17 87 -ve -ve NIL NIL 3-4 NIL NIL 2-1 NIL NIL NIL NIL 
4 2290 7900 8500 52 
56 
46 46 2 1 10 11 4 9 4 8 82 16 207 100 17 198 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
5 2833 8000 8700 52 
56 
45 46 4 2 11 12 1 9 4 8 98 18 140 95 20 120 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
6 2755 8000 9000 56 
58 
42 42 2 1 9.8 10 1 24 1 3 80 25 155 80 22 150 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
7 3113 9800 9600 74 
72 
23 26 3 2 11 11 11 3 5 12 88 25 154 80 22 150 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
8 3110 9200 9300 62 
64 
23 25 5 1 9.5 10 25 52 10 20 78 27 165 90 20 165 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
9 3211 7900 8000 68 
70 
30 32 2 1 12 12 4 9 4 8 83 38 226 80 38 220 -ve -ve NIL NIL 2-3 NIL NIL NAD NIL NIL NIL NIL 
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10 3638 9200 8500 75 
75 
22 24 3 1 11 12 1 3 1 3 89 - 207 80 - 200 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
11 50900 8900 8500 62 64 30 28 2 1 12 12.5 10 20 5 10 90 20 - 90 - - -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
12 40831 9300 8600 58 60 32 34 10 5 12 12 5 12 3 5 72 - 186 70 20 100 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
13 40453 10,800 9500 70 72 25 26 5 3 11 12 4 8 2 4 114 - 294 100 - 90 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
14 48096 8200 8500 50 52 45 46 2 1 10 11 9 18 1 3 80 20 171 80 24 85 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
15 47767 8000 8600 49 51 48 47 3 1 12 11.5 2 5 1 3 62 30 231 90 25 100 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
16 65513 7300 8300 58 60 39 38 3 2 14 13.5 2 5 2 4 109 23 177 100 23 120 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
17 65550 8800 8000 52 54 44 43 4 1 11 11 4 9 1 3 194 34 114 115 35 115 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
18 61074 7900 7500 64 66 32 30 4 3 8 9 4 9 1 5 87 42 227 80 30 80 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
19 52462 8500 8000 54 56 43 42 3 1 11 11 3 7 1 4 102 - 142 70 - 90 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
20 45112 9000 9000 56 58 42 44 2 1 8 9 4 8 2 5 80 20 155 75 20 75 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
                                  
 
TC - Total Count, DC- Differential Count, P - Polymorphs, L- Lymphocytes, E- Eosinophils, HB- Hemoglobin, ESR-Erythrocytes sedimentation Rate 
         
 
BT- Before Treatment, AT- After treatment, BS- Blood sugar, BU- Blood Urea, SC-Serum cholestrol,NAD-No abnormal Defect 
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S. 
0P. 
NO & 
IP NO 
TC 
DC ESR   
Skin 
Scrapping 
for 
fungus Urine Analysis Motion Analysis S. 
NO P L E HB % BT AT BT AT 
BT AT 
BT AT BT AT NO 
  
BT AT BT AT BT AT BT AT BT AT 1/2 
hr 
1 
hr 
1/2 
hr 
1 
hr 
BS BU SC BS BU SC Alb Sug Dep Alb Sug Dep Ova Cyst Ova Cyst 
  
21 42109 7000 9100 60 58 30 28 1 1 8 10 4 8 2 4 94 20 310 80 22 300 -ve -ve NIL NIL 3-4 NIL NIL 1-2 NIL NIL NIL NIL -5371.9 
22 57825 9000 8000 56 58 40 38 4 2 9 9 2 5 2 5 84 - 145 84 18 140 -ve -ve NIL NIL 2-3 NIL NIL 1-2 NIL NIL NIL NIL -7659.7 
23 54236 9000 8500 59 60 38 36 3 1 11 12 3 7 3 7 77 - 174 75 - 150 -ve -ve NIL NIL 3-4 NIL NIL 2-1 NIL NIL NIL NIL -7264 
24 52206 8000 8000 70 71 24 26 6 4 10 11 3 7 3 7 70 20 212 80 23 200 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -6935 
25 55896 9200 9000 56 58 34 32 10 8 11 11 10 22 5 10 98 30 98 90 28 100 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -7228.3 
26 52307 9100 9000 52 50 26 24 2 1 8 8 8 15 4 8 120 20 151 100 23 120 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -7072 
27 56896 9500 9500 68 70 30 28 2 1 10 11 4 8 4 8 123 23 146 120 23 130 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -7650 
28 46654 7900 8000 62 60 36 34 2 1 8 9.5 3 6 1 3 98 34 140 90 30 120 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -6288.1 
29 51310 9100 9000 55 58 40 40 3 2 8 9 20 45 9 20 78 42 222 80 28 200 -ve -ve NIL NIL 2-3 NIL NIL NAD NIL NIL NIL NIL -6949.8 
30 52623 8000 8500 68 65 30 28 2 1 11 12 15 30 5 11 70 - 152 75 - 130 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -7000.1 
31 45113 7000 8000 60 58 38 36 4 2 12 12 25 55 10 22 77 20 176 75 20 150 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -5818.4 
32 47462 11400 9000 74 72 20 18 6 4 13 13 14 35 7 10 78 30 172 80 30 160 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL -6685.5 
33 41510 8,700 8500 65 68 30 32 5 3 10 10 5 12 2 6 72 - 134 82 20 120 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -5774.4 
34 48609 9000 8000 60 62 34 36 6 5 10 11 5 10 3 8 76 - 288 76 - 250 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -6596.1 
35 43017 8100 9500 68 70 30 32 2 1 14 14 5 10 2 4 98 32 220 80 30 200 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -5939.7 
36 45168 8500 9000 69 65 20 18 3 1 10 10 12 27 5 10 95 24 212 85 35 210 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -6201.9 
37 40594 8900 8000 62 60 36 34 2 1 11 11 1 2 1 2 81 19 161 70 25 110 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -5666.7 
38 43835 9900 9000 65 64 32 30 3 2 11 12 4 8 4 8 82 - 171 85 - 150 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -6155.2 
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39 48407 7900 8000 66 68 30 28 4 2 11 12 1 2 1 2 90 18 186 90 29 180 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -6491.5 
40 41899 7800 7500 56 58 28 26 3 1 10 11 2 4 2 1 95 33 294 98 30 250 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL -5715.2 
                                   
  
TC - Total Count, DC- Differential Count, P - Polymorphs, L- Lymphocytes, E- Eosinophils, HB- Hemoglobin, ESR-Erythrocytes sedimentation Rate 
     
  
BT- Before Treatment, AT- After treatment, BS- Blood sugar, BU- Blood Urea, SC-Serum cholestrol,NAD-No abnormal Defect 
          
0P. NO 
& IP 
NO 
TC 
DC ESR 
P L E HB % BT AT 
BT AT BT AT BT AT BT AT BT AT 
1/2 hr 2 hr 1/2 hr 2 hr 
-6530.4 -7688.9 -8847.4 -10006 -11164 -12323 -13481 -14640 -15798 -16957 -18115 -19274 -20432 -21591 4 
-9578.8 -11498 -13417 -15336 -17255 -19174 -21094 -23013 -24932 -26851 -28770 -30689 5 2 5 
-9092.8 -10922 -12750 -14579 -16408 -18236 -20065 -21894 -23723 -25551 -27380 -29209 7 3 7 
-8678 -10421 -12164 -13907 -15650 -17393 -19136 -20879 -22622 -24365 -26108 -27851 7 3 7 
-8900.4 -10572 -12245 -13917 -15589 -17261 -18933 -20605 -22277 -23949 -25621 -27293 -28965 15 20 
-8858.2 -10644 -12431 -14217 -16003 -17789 -19576 -21362 -23148 -24934 -26721 -28507 15 4 8 
-9579.6 -11509 -13439 -15369 -17298 -19228 -21157 -23087 -25017 -26946 -28876 -30806 8 4 8 
-7876.5 -9464.9 -11053 -12642 -14230 -15818 -17407 -18995 -20584 -22172 -23760 -25349 6 1 3 
-8708.3 -10467 -12225 -13984 -15742 -17501 -19259 -21018 -22776 -24535 -26293 -28052 45 9 20 
-8762.6 -10525 -12288 -14050 -15813 -17575 -19338 -21100 -22862 -24625 -26387 -28150 30 5 11 
-7169.9 -8521.4 -9872.8 -11224 -12576 -13927 -15279 -16630 -17982 -19333 -20685 -22036 -23388 34 46 
-8389.2 -10093 -11797 -13500 -15204 -16908 -18612 -20315 -22019 -23723 -25427 -27130 35 7 10 
-7247.3 -8,720 -10193 -11666 -13139 -14612 -16085 -17558 -19031 -20504 -21977 -23450 12 2 6 
-8262.3 -9928.5 -11595 -13261 -14927 -16593 -18259 -19925 -21592 -23258 -24924 -26590 10 3 8 
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-7457.4 -8975 -10493 -12010 -13528 -15045 -16563 -18081 -19598 -21116 -22634 -24151 10 2 4 
-7779.2 -9356.5 -10934 -12511 -14088 -15666 -17243 -18820 -20398 -21975 -23552 -25130 27 5 10 
-7110.8 -8555 -9999.1 -11443 -12887 -14332 -15776 -17220 -18664 -20108 -21552 -22996 2 1 2 
-7726.8 -9298.3 -10870 -12442 -14013 -15585 -17156 -18728 -20299 -21871 -23443 -25014 8 4 8 
-8128.4 -9765.3 -11402 -13039 -14676 -16313 -17950 -19587 -21224 -22861 -24497 -26134 2 1 2 
-7162.8 -8610.4 -10058 -11506 -12953 -14401 -15848 -17296 -18744 -20191 -21639 -23086 4 2 1 
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ESR   
Skin Scrapping 
for fungus Urine Analysis Motion Analysis 
BT AT BT AT 
BT AT 
BT AT BT AT 
1/2 hr 2 hr 1/2 hr 2 hr 
BS BU SC BS BU SC Alb Sug Dep Alb Sug Dep Ova Cyst Ova Cyst 
-19274 -20432 -21591 4 218.267 241.295 264.324 287.352 310.381 333.41 -ve -ve NIL NIL 3-5 NIL NIL 1-2 NIL NIL NIL NIL 
-30689 5 2 5 84 - 76.5 68.4 60.3 52.2 -ve -ve NIL NIL 2-4 NIL NIL 1-2 NIL NIL NIL NIL 
-29209 7 3 7 77 - -24 -123 - 150 -ve -ve NIL NIL 3-5 NIL NIL 2-2 NIL NIL NIL NIL 
-27851 7 3 7 153.533 168.59 183.648 198.705 213.762 228.819 -ve -ve NIL NIL 1-3 NIL NIL NAD NIL NIL NIL NIL 
-27293 -28965 15 20 73.6 73.4857 73.3714 73.2571 73.1429 73.0286 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-28507 15 4 8 84.8 83.6 82.4 81.2 80 78.8 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-30806 8 4 8 95.0667 95.3238 95.581 95.8381 96.0952 96.3524 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-25349 6 1 3 90.1333 91.5048 92.8762 94.2476 95.619 96.9905 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-28052 45 9 20 150.933 163.105 175.276 187.448 199.619 211.79 -ve -ve NIL NIL 2-4 NIL NIL NAD NIL NIL NIL NIL 
-28150 30 5 11 70 - -2 -79 - 130 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-22036 -23388 34 46 112.733 120.276 127.819 135.362 142.905 150.448 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-27130 35 7 10 123.467 132.552 141.638 150.724 159.81 168.895 -ve -ve NIL NIL 1-2 NIL NIL NAD NIL NIL NIL NIL 
-23450 12 2 6 72 - 63 52.6 42.2 31.8 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-26590 10 3 8 76 - -136 -348 - 250 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-24151 10 2 4 146.4 156.8 167.2 177.6 188 198.4 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-25130 27 5 10 158.267 172.01 185.752 199.495 213.238 226.981 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-22996 2 1 2 84.8667 86.9238 88.981 91.0381 93.0952 95.1524 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-25014 8 4 8 82 - -1 -87 - 150 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-26134 2 1 2 137.533 148.59 159.648 170.705 181.762 192.819 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
-23086 4 2 1 190.333 206.619 222.905 239.19 255.476 271.762 -ve -ve NIL NIL NAD NIL NIL NAD NIL NIL NIL NIL 
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Name : Susairathnam 
Age / Sex  : 64 /M 
Before Treatment 
 
 
 
 
After Treatment 
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Discussion 
Vatha karappan 
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DISCUSSION 
          The main characteristic features of “Vatha Karappan” are itching, oozing, 
erythema, oedema, vesicles and papules. This disease can be more or less 
correlated with “Eczema” in modern medicine. 
Causative factors 
 According to the Siddhars view, it was stated that excessive intake of fish, 
mutton, low grade food materials like meat, varagu, thinai, rhizomes and root of 
some plants are the main causes for this disease. Also all the anti - social activities 
result in psychic disturbances leading to this disease. 
 Regarding to the etiology of “Eczema” in modern medicine, 
hypersensitivity to variety of contact allergens (plants, cosmetics, clothing and 
medicaments), irritants (physical and chemical) history of allergies, emotional 
factors and familial predisposition are the causes. 
         This dissertation work includes a literary collection of views both Siddha 
and modern aspects of this disease. For the clinical study of 40 patients, they were 
diagnosed clinically, as Vatha Karappan, as per the symptamatology and the 
Envagai thervugal and other Siddha methods of diagnosis were selected, in that 10 
patients were admitted in inpatient ward and 30 patients were treated as out 
patients. 
          On the day of enrollment, routine lab investigations (Blood, and urine tests), 
general and systemic examinations, Neerkuri and Neikuri were done in all 40 
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patients in both Siddha and modern aspects. An individual case sheet was prepared 
and maintained in all the patients. 
         On early morning, the next day of admission Vellai ennai 15 ml was given as 
the initial treatment of skin disease for neutralizing the vitiated vaadham to some 
patients. 
        The internal medicine Perumarapattai chooranam 1gm tds with water after 
meals and the external medicine Pungu thylum were given to all patients 
regularly. All the patients were advised to follow pathiyam, yogasanam, prayanam 
and thiyaanam as supportive measures to relieve mental stress and strain. 
  1) SEX DISTRIBUTION: 
 40 patients of both sexes were selected for the dissertation study.  Among 
40 cases, 26 were males and 14 were females.  The sex incidence is higher in 
males than females. According to the Siddha literatures, there is no apparent sex 
predilection in Vatha Karappan. Males are become vulnerable victims because of 
their occupational indifference, mental strain, faulty life styles, when compared to 
females. 
2) AGE DISTRIBUTION: 
 During this study, the prevalence of Vatha Karappan was a common one 
affecting the adult age group mainly above 50 years. 
 
 
105 
 
3) KAALAM DISTRIBUTION: 
          Out of 40 patients, 
          75% of the patients belonged to Pitha Kaalam. 
          15% of the cases belonged to Kabha kaalam. 
          10% of the patients belonged to Vatha Kaalam. 
          These research study shows that more patients were affected in Pitha 
Kaalam. 
4) OCCUPATIONAL STATUS: 
           Occupational hazards play a major role in causing or aggravating the 
disease Vatha Karappan. 
5) SOCIOECONOMIC STATUS: 
             Out of 40 patients, 32 were belonged to poor economic conditions. 
Majority of them were ignorant of personal hygiene. Malnutrition, prolonged and 
persistent exposure to polluted atmosphere, lowered immune responses made them 
prone to this type of disease. 
6) DIET REFERENCE: 
           During the study, 95 patients were mixed dietary habits. Also some food 
stuffs like ragi, brinjal, maize, tomato and fish items can be the causative factors 
for Vatha Karappan. So they were advised to avoid those items. 
         Constipation was present in 10 cases, which also intensified the condition. 
Hence they are advised to consume fiber rich diet and plenty of water intake. 
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7) SEASONAL REFERENCE: 
           Skin diseases are prone to have definite seasonal influences. 
 Out of 40 patients, 18 patients were affected in Pinpani kaalam, 8 patients 
were affected in Munpani and Mudhuvenil kaalam, 6 patients were affected in 
Elavenil kaalam. 
8) THINAI:  
  100% of patients belonging of Marutha Nilam. Siddha literature reveals that 
Marutha Nilam is a Place that can be regarded as “Disease free Zone” and cures all 
the disease.  Here Patient developed the disease due to alteration in their food 
habits and routine activities and the uses of too much of pesticides and chemicals. 
9) MODE OF ONSET: 
           During the study out of 40 cases, 70% cases were found to be observed to 
be chronic onset. Incomplete treatment, failure to follow medical advice and 
dietary restrictions, psychological strains and changed life style were observed to 
be the reasons for this disease to be chronic. 
10) AETIOLOGY: 
          All type of etiological factors was observed during the study, as Vatha 
Karappan is one among the immunological disorders like bronchial asthma, which 
may affect subsequent generations. Also positive family history and incompatible 
diet was found in 3 cases, occupational relevant in 19 cases, irritants or allergens  
in 8 cases, insect bite in 5 cases and psychological stress and strain  in 2 cases were 
also noted. 
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11) REFERENCE OF MUKKUTRAM: 
      a) Affected Vatham:   
1. Pranan was affected in 6 cases (Bronchial asthma). 
2. Abanan was affected in 10 cases (Constipation). 
3. Thevathathan affected in 7 cases. It is responsible for sleep and anger.  
4. Viyanan and Samanan affected 100% of cases. It is responsible for all 
the movement of the body.  
b) Affected Pitham: 
1. Anar Pitham was affected in 3 cases (loss of appetite). 
2. Ranjaga Pitham was affected in 7 cases - It gives colour to the blood.  
(Decreased hemoglobin). 
3. Prasaga Pitham was affected in all the cases - It gives complexion to 
the skin.(Vesicles, oozing, dryness, roughness and hyper pigmentation). 
4. Sathagam was affected in 11 cases (inability to do normal works).        
c) Affected Kabham: 
1. Avalambagam was affected in 6 cases (Bronchial asthma). 
2. Kilethagam was affected in 3 cases - It gives partial digestion of food. 
3. Santhigam was affected in 10 cases (joint pain). 
12) IN UDAL KATTUKKAL:  
                 Among the seven udarkattukal, 
1) Saaram was affected in all cases (depression, lethargy). 
2) Senner was affected in all cases (vesicles, papules). 
3) Oon was affected in all cases (vesicles, oozing). 
4) Kozhuppu was affected in 4 cases (ulcer). 
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13) IN ENVAGAI THERVUGAL: 
        Among the 40 cases, 
1.  Niram (colour changes) and sparisam (heat to touch) were affected in 
100% of cases. 
2. Naadi   of patients   have the higher incidence of Pitha Vatham in 33 
cases, and Vatha Kabham in 7 cases. 
13) REFERENCE OF NEERKURI AND NEIKURI: 
 In Neerkuri 100% of patients had straw coloured urine.  
In Neikuri process the oil resembled that, in 10 cases spreading like pearl, 
in 30 cases spreading like snake. 
INVESTIGATION: 
 Besides Siddha investigation, the modern diagnostic procedures were also 
done.  Routine examinations of blood urine and other investigation, procedures 
were carried out in the patients. 
MANAGEMENT: 
 Siddha system the treatment is based on the deranged Dhosa. The deranged 
Vatha are brought down by Viresanam respectively. 
Initially, 
 Vellai ennai- 15ml with hot water in empty stomach at early morning. 
DRUG: 
Internal: 
1) PERUMARAPATTAI CHOORNAM:  1gm three times a day          
with  water               
External: 
2) PUNGU THYLUM 
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  The trial drugs were administered to the patients from the time of 
admission in the in-patients ward and continued till the symptoms reduced. The 
treatments aimed at providing relief from symptoms and control the 
predisposing factor diet restrictions was instructed to the patient during the 
course of treatment. 
During discharge, the patient was advised to follow yogasanas and     
pranayamam. These helped them to prevent recurrences and patients felt well 
in doing them. 
 
RESULT: 
 Good relief:   72.5% 
 Moderate relief: 27.5% 
 No toxic (or) side effect were clinically and reportedly observed in any case 
during the course of the treatment. 
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SUMMARY 
 The dissertation work on Vatha Karappan was chosen by the author, with 
an intention to give physical and mental and also clinical relief to the 
patients those who are suffering from this disease, with out any side 
effects. 
 The literature evidence was collected from Yugi Vaithiya Chindamani and 
the drug evidence from Agathiyar 2000 and Yugi Muni Vaithiya 
Kaaviyam. 
 40 Patients were selected across different age and sex category from the 
Post Graduate Sirappu Maruthuvam Department, Govt.Siddha Medical 
College, Palayamkottai, for study purposes. 
 The signs and symptoms of Vatha Karappan are mostly related to eczema 
in modern aspects. 
 History, Clinical findings, Laboratory results, Envagai thervugal, Udal 
thathukkal and Uyirthathukkal were used for the diagnostic purpose. 
 They were treated with “Perumarapattai chooranam’’ (Internal) and 
“Pungu thylam” (External). 
 The general improvement of the patient condition was observed from the 
end of the first week itself. 
 Along with medication, the patients were advised over their dietary habits 
and to practice prayanamas and yoga. 
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 The clinical findings reveal about the disease and its impact in the body, 
statistics taken with the help of details in the case sheet, were dealt in 
details in observation and results which gave clear knowledge about the 
disease. 
 During and after the course of treatment no side effects were reported. 
 The efficacy of the drugs was studied by Bio-chemical analysis and 
pharmacological analysis. 
 The result of the biochemical analysis is concluded that the drug 
Perumarapattai Chooranam indicates the presence of Calcium, Starch, 
unsaturated compound, reducing sugar and amino acid. 
 The result of the pharmacological study is concluded that the drug 
Perumarapattai Chooranam has  
 Significant anti histamine action. 
 Significant acute and chronic inflammatory action. 
            Pungu thylam has 
 Significant acute anti inflammatory action. 
 The above results shown that the trial drug Perumarapattai chooranam 
(internal) and Pungu thylam (external) has clinically significant action. 
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CONCLUSION 
 When Perumarapattai chooranam and Pungu thylum were administered to 
the Vatha Karappan patient, following results were observed. 
 Results show that 72.5 % of patients showed good relief and 27.5% cases 
had moderate relief. 
 The disseration drug was very effective to the patients and there was no 
recurrences of symptoms were reported. 
 Cost of the drug is very cheap and free from side effect. So they are useful 
for long term purposes 
  Hereby the author concludes that the treatment with drug Perumarapattai 
Chooranam (internal) and Pungu thylam (external) for Vatha Karappan 
was found very effective in point of efficacy and safety. 
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ANNEXURE I 
PROPERTIES OF TRIAL MEDICINE 
PERUMARAPATTAI CHOORANAM 
INGREDIENTS: 
Perumarapattai                 -       500 mg 
Chukku      -       500 mg 
Seeragam   -       500 mg 
Kadugurohini  -       500 mg 
Citraarathai      -       500 mg 
Kandankathiri  -       500 mg 
Sengatharai pattai               -       500 mg 
Karungeeragam  -       500 mg 
Sangam ver   -       500 mg 
Method of purification:  
    The drug has to been cleaned thoroughly and washed with water and allowed to 
dry in sunshade. 
Method of preparation: 
 Purified drug is heated in frying pan and grinded well into fine powder and 
filtered with pure white cloth (vasthrakayam).Then the powder is collected and 
preserved in the air tight container. 
 “fue;jpL ngUkuj;jpw; fz;lq;fj; jphpAQ;ff;Fs; 
 Rue;jpL nrq;fj;jhhp njhd;Dr; ufkpuz;L 
 gue;jpL fLFNuhfpzp gfHrq;F kuj;ij $l;b 
 epue;jpb kpjidf; nfhs;s ePq;fpLq; Jug;gd;whNd” (ghly; - 44) 
mfj;jpaH 2000 %d;whk; ghfk; g.vz;. 73  
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CHUKKU: (Rf;F) 
NtW ngaH  -    mUf;fd;> mjfk;> tpl%ba mkpHjk; ehfuk; 
Botanical name: Zingiber officinale 
 Family: Zingiberaceae 
Rit           -    fhHg;G 
jd;ik      -    ntg;gk; 
gphpT          -    fhHg;G 
nghJ Fzk;: 
             #iy ke;jk; neQ;nrhpg;G NjhlNkg; gk;koiy 
      %yk; ,iug;gpUky; Kf;FePH - thyfg; 
     Njhlkjp rhuw; njhlHthj Fd;kePHj; 
     Njhlk; Mkk;Nghf;FQ; Rf;F. 
 nrhpahik> GspNag;gk;> ntg;gk;> ,iug;G ,Uky;> fopr;ry;> ePNuw;wk;> Fd;kk;> 
jiyNeha;> jiytyp> ghz;L> IaRuk; Nghk;. 
Uses: Rhizomes forms the source of the drug ginger which is used as a carminative 
and stimulant, are also given in flatulence and colic. 
Chemical constituents: Rhizomes contain the following chemical constituents such 
as Essentiol oil, Ginger diol, Zingeberene, Zingeberol, Curcumin, Oleoresin, 
gingerin, gingerol. 
CHEERAGAM (rPufk;) 
NtW ngaH mir> rPhp> cgFk;ggprk;> ew;rPhp> gpj;jehrpdp> Nkj;jpak; 
Botanical name : Cuminum cyminum 
Family – Apiaceae 
Rit     -   fhHg;G> ,dpg;G 
jd;ik  -   jl;gk; 
gphpT     -   ,dpg;G 
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Medicinal properties:  Carminative, stomachic, astringent, anthelmintic, digestive, 
constipating.  
Uses: Asthma, colic, dyspepsia, fever, flatulence, helminthiasis, leprosy, 
leucorrhea, skin disease, vomiting. 
KARUNGEERAGAM (fUQ;rPufk;)  
NtW ngaH - muzk;> cgFQ;rpif 
Botanical name: Nigella sativa 
Family: Ranunculaceae  
Rit       -    ifg;G 
jd;ik    -   ntg;gk; 
gphpT       -    fhHg;G 
nghJ Fzk;: 
           ‘fUQ;rPufj;jhd; fug;gFdhL Gz;Zk; 
    tUQ;rPuha;g; gpUrK khw;Wk; mUe;jjpdhy; 
    fha;r;ry; jiytypAq; fz;tspAk; NghKyfpy; 
    tha;r;r kUe;njdNt it.” 
Fzk; - kz;ilf;fug;ghd;> Gz;> cl;#L> jiyNeha;> fz;Nzha;> rpuq;F> 
tapw;WnghUky;> Fd;kk;> khHGtyp> ,Uky;> tPf;fk;> fhkhiy MfpaitfSk; 
fUQ;rPufj;jhy; ePq;Fk;. 
Chemical constituents:  Nigellone, Nigellicin alkaloid, volatile oil, fatty acids, 
oleic acid, melantin, metarbin. 
Medicinal properties: Anthelmintic, anti-inflammatory, thermogenic, fermifuge, 
carminative, diuretic, expectorant, digestive. 
Medicinal uses:  Diarrhoea, eczema, skin disease, amennorhea, dyspepsia, 
fever, flatulence, leucoderma, leprosy, and jaundice. 
126 
 
KADUGUROHINI (fLFNuhfpzp):  
NtW ngaH - flfNuhfpzp> fLNuhfpzp 
Botanical name: Picrorhiza kurroa 
Family: Scrophularaceae  
 Rit     -    ifg;G> fhHg;G 
 jd;ik   -   ntg;gk; 
 gphpT      -   fhHg;G  
nghJ Fzk;: 
           ‘ khe;jQ; Ruikak; thAfuk; ghdhkQ;  
                    NrHe;jkyf; fl;L jphpNjhlk; -Nghe;jngl;Lg;  
                    Gz;tapW NehapitNghk; nghw;fhGNa 
                    jpzfLF Nuhfzpf;Fj; NjH.” 
 Fzk; -khe;jk;>Ruk;> fug;ghd;> rPjf;fopr;ry;> tapw;Wtyp> Gz;fs; ,itfis 
Nghf;Fk;. 
Chemical constituents: Rhizome contains a bitter glucoside, katkin, apocyanin, 
picrorhizin, kutkin, vannilic acid. 
Medicinal properties: Acrid, anthelmintic, anti-inflammatory, carminative, 
digestive, expectorant  
Uses:  Fever, eczema, respiratory disorder, amenorrhoea. 
CITRAARATHAI (rpw;wuj;ij) 
Botanical name: Alpinia galangal 
Family: Zingiberaceae  
Rit      -   fhHg;G 
tphpak;    -    ntg;gk; 
gphpT      -    fhHg;G 
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nghJ Fzk;: 
                     ‘thjgpj;jq;fug;ghd; thjQ; rpNuhNuhfQ; 
            NrHe;jfg Kj;NjhlQ; rPjnkhL - Nehe;jRuk; 
              kw;wuj;ijf; fhl;b tUkpUk xe;jPUk; 
              rpw;wuj;ij td;kUe;jhy; NjH.”  
                                                          (NjF) 
     tspIaf; Fw;wq;fs;> fug;ghd;> thA> jiyNeha; > ,Uky;> gy Ruk; Mfpa 
,itfis Nghf;Fk;. 
Chemical constituents:  Essential oil, quercetin, kaempferol, kaemferide, quercetin 
3 methyl ether, galagin, galanolactone, galangal A&B. 
Medicinal properties:  Acrid, aphrodisiac, aromatic, bitter, carminative, 
expectorant, febrifuge, stimulant, stomachic, 
Uses: Skin disease, indigestion, joint pain, fever, ddyspepsia, leucoderma, piles, 
and diabetes. 
KANDANGKATHIRI VER (fz;lq;fj;jphp Nth;) 
Botanical name: Solanum surattense 
Family: Solanaceae  
Rit         -     fhHg;G 
jd;ik     -     ntg;gk; 
gphpT        -     fhHg;G 
Chemical constituents: Beta carotene, scopoletin, diosgenin, glucoside, beta 
sitosterol, arachidic acid, linoleic acid, oleic acid, palmitic acid, diosgenic. 
Medicinal properties: Alterative, anthelmentic, antiasthamatic, digestive, febrifuge, 
bitter, pungent. 
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SENGATHARAI PATTAI  
Botanical name: Capparis aphylla 
Family: Capparaceae 
Chemical constituents: Spermidineall, used for inflammation, asthma, and gout. 
Uses: Boils, eruptions, vomit, arthritis, chronic and foul ulcers, cardiac debility. 
SANGAN VER (rq;fd; Nth; );  
NtW ngaH - rq;fQ;nrb> xw;rq;fd;> Kl;rq;fd; 
Botanical name: Azima tetracantha 
Family: Verbenaceae 
Rit        -   ifg;G 
jd;ik      -   ntg;gk; 
gphpT         -   fhHg;G 
nghJ Fzk;: 
                     ‘rq;fk;NtHg; gl;il rspapUkiyr; Ruj;ij 
              mWfth jf;fLg;ig Mlijg;igg; - gq;fNk 
              nra;Aq; fpuw;jpiaAs; jPfhy; fpUkpiaapt; 
              itaw; jdpnyhopf;F khy;.” 
Chemical constituents: Plants contain clerodane diterpleno-clerodermic acid, 
friedelin, methoxy flavones, acacetin, apigenin. 
Uses: Glandular swelling, eczema, leucorrhea, scabies, pain in disease of vatham, 
snake bite.  
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PERUMARAM (ngUkuk;; ) 
NtW ngaH      -    gPehwp kuk;  
Botanical name: Sterculia foetida 
Family: Sterculiaceae 
Rit              -     ifg;G 
jd;ik           -     ntg;gk; 
gphpT              -      fhHg;G 
nghJ Fzk;: 
‘ngUkug; gl;ilaJ Ngjp fpuhzp 
          kUtpuj;j Nehapdj;ij khw;We;jpUNt 
          eliyGhp thjj;ij ehlnj Rw;Wk; 
          cliyapul; rpf;Fnkd NthJ.” 
,jdhy; fopr;ry; Neha;fSk;> tapw;iw gw;wpa Neha;fSk;> FUjp 
Neha;fSk;> tspf;Fw;wg; ngUf;fhy; tUk; Neha;fSk; Nghk;. 
Chemical constituents:  Flavanoids, glycosides, phenylporpanoid glucose ether, 
fixed oil, saponin and alkaloids. 
Medicinal properties: laxative, astringent. 
Uses    : Decotion of leaves useful in skin eruptions, and difficult labour, oil paste 
in pruritc conditions, seed oil internally given for ithching and skin disease. 
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PUNGU THYLUM 
INGREDIENTS: 
Pachai manjal               -    50 gm 
Vellai paashanam         -    10 gm 
Vetpalai arisi                -    200 gm 
Pungu ennai                 -    1 litre 
Vallarai juice               -    1 litre 
Gingely oil                  -    1 litre 
 Method of preparation:  
The powdered vetpalai seeds and the purified white arsenic were grinded 
with vallarai juice and then mixed with equal proportion of Pungu ennai, gingely 
oil and vallarai juice.Then the proportion is heated until it reaches the thylam 
consistency. 
Reference: Yugi Muni Vaithiya Kaaviyam Pg.No -299   
MANJAL (kQ;rs;) 
NtW ngaH -  mhprdk;> fhd;> rdp> ePrp> gPjk; 
Botanical name: Curcuma longa 
Family: Zingiberaceae.    
Rit      -     fhHg;G> ifg;G 
jd;ik    -     ntg;gk; 
gphpT       -      fhHg;G 
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nghJ Fzk;: 
          ‘nghd;dpwkhk; Nkdp Gyhdhw;wKk; NghFk; 
           kd;D G&k trpakhk; - gpd;dpnaOk; 
           the;jp gpj;j Njhlikak; thjk; Nghe; jPgdkhq; 
           $He;j kQ;rspd; fpoq;Ff;Nf”  
                                                 -mfj;jpaH Fzthflk; 
 
             clypy; G+rp Fspf;f cly; nghd;dpwkhFk;. Gyhy; ehw;wk; NghFk;. 
grpAz;lhFk;> the;jp> tsp> jP> Iaf;Fw;wk;> jiytyp> ePNuw;wk;> nts;is> [tif 
typ> tPf;fk;> tz;L;fb> ngUk;Gz; NghFk;. 
 Chemical constituents:  Curcumin, zingiberine, curcuminides, turmeric oil, 
aromatic oil, 
Medicinal properties:  Anthelmintic, anti parasitic, stomachic, carminative, 
stimulant, blood purifier, alteratiive, hepatic tonic. 
Medicinal uses: Whooping cough, bleeding piles, leprosy, skin disease. 
 
VALLARAI ( ty;yhiu) 
NtW ngaH - rz;lfp> gpz;Bhp> Nahrdty;yp 
Botanical name: Centella asiatica 
Family - Apiaceae 
Rit      -   JtHg;G> ifg;G> ,dpg;G. 
jd;ik   -    jl;gk; 
gphpT      -    ,dpg;G 
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nghJ Fzk;: 
               ‘mf;fu Neha; khWk; mfYk; tapw;wpop  
                jf;ftpuj; jf;fLg;Gj; jhNdFk; - gf;fj;jpy; 
                vy;Nyhiu AkUe;njd; NwAiuj;J ed;kidAs; 
                ty;yhiu iatsHj;J it.” 
 tha;g;Gz;> fopr;ry;> ntwp> ahidf;fhy;> Nkfg;Gz;> fhak;> fl;b> 
tPf;fk;> gil> fz;lkhiy> Rjff;fl;L Mfpad jPUk;. 
 
Chemical constituents: Vallerine, asiaticoids, sitosterol, tannin, oxy asiaticocide, 
triterpene acids, alkaloids, flavanoids, and glycosides. 
Medicinal properties: Anti bacterial, anti inflammatory, anti ulcerogenic, 
anxiolytic, cerebral tonic, circulatory stimulant, diuretic, antioxidant,. 
Medicinal uses: Wound healing, leprosy, detoxification, relieve hypertension, 
immunomodulator. 
GINGELY OIL (ey;nyz;nza;) 
NtW ngaH -   jpyk; 
Botanical name: Sesamum indicum 
Family: Pedaliaceae  
Rit     -     ,dpg;G 
jd;ik   -    ntg;gk; 
gphpT      -    fhHg;G 
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nghJf;Fzk;: 
  ‘Gj;jp eadf; FspHr;rp G+hpg;G nka;g;GifQ; 
   rj;Jtq; fw;jpdpapdik - nkj;j Tz;lhq; 
   fz;Nzha; nrtpNeha; fghytoy; fhrNeha; 
   mz;Nzha; Nghnkz;nzahw; Nghw;W”  
                                                          - mfj;jpaH Fzthflk; 
              ,j;ijyj;ij ,uz;L (m) ehY cr;rp fuz;basT cs;Sf;F ju cly; 
G+hpf;Fk;. jpdT> gil> nrhwp> rpuq;F> ePq;fp Njhy; moF ngWk;. ,Uky; jzpAk;. 
Chemical constituents: Sesamin, sesamolin, phytrosterol, Vit E, carbohydrates, 
fixed oil, mrystic acid, palmitic acid, stearic acid, arachidic acid, oleic acid, 
linoleic acid. 
PUNGU ( Gq;F)  
NtW ngaH -  Gd;F> G+e;jp> fuQ;rfk;> fuQ;rk; 
Botanical name: Pongamia glabra 
Family: Papillonaceae  
Rit     - ifg;G> JtHg;G 
jd;ik   - ntg;gk; 
gphpT      - fhHg;G 
Gq;F vz;nza; 
nra;if 
Antiseptic 
 Stimulant 
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 nghJf;Fzk;:  
                  ‘Gq;F tpij fhw;fpue;jp Gz; fug;ghd; fhnjOr;rp  
                  mq;frd;dp fz;Nzha;f;Fk; Mk;Ngjp – Awfl;Lk; 
                   fhl;Lg;Gq;fpd; tpijf;F fz;lNj kw;nrhwpaNka;g; 
                 Ml;Lg;Gq; fpd;tha;Tk; Nghk;.” 
Fzk; - ,jdhy; fhy; Gz;> fpue;jp> fug;ghd;> fhJNeha;> Kg;gpzp> ePq;Fk;. 
fhl;Lg;Gq;fpd; tpijapdhy;> NjkYk;> gilAk;> fPy;fisg; gw;wpa tha;Tk; Nghk;. 
Chemical constituents: Glabrin, pongaopin, furanoflavones, karangin, pongamaol, 
beta sitosterol. Karangin is the active principle responsible for the curative effect 
of the oil in skin diseases.    
Medicinal uses: Herpes, scabies, sores and eczema. 
 
ARSENIC 
English name: Arsenum 
Chemical name: Acidum arsenioum 
Characters: The by product, arsenious exists as solid, heavy white powder, minute 
transparent or glass like crystals. It is tasteless and soluble in water. Action: In 
very small doses it is stomachic, general and nervine tonic, alterative, anti periodic, 
cardiac, respiratory, intestinal and sexual stimulant. 
Uses: It is used in variety of disease but chiefly in fever. To increase immunity 
from disease arsenic is administered in gradually increasing doses. 
Externally, it is used to remove large growth as in cancer and in lupus. 
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ANNEXURE II 
BIO-CHEMICAL ANALYSIS OF 
PERUMARAPATTAI CHOORNAM 
Preparation of the extract: 
 5gms of choornam was weighed accurately and placed in a 250ml clean 
beaker. Then 50ml of distilled water is added and dissolved well.  Then it is boiled 
well for about 10 minutes.  It was cooled and filtered in a 100ml volumetric flask 
and then it is made up to 100 ml with distilled water.  This fluid is taken for 
analysis. 
Qualitative analysis: 
S.No Experiment Observation Inference 
1. TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube.  Add 2 ml of 4% 
ammonium oxalate solution is 
added to it 
A white precipitate 
is formed  
Indicates the 
presence  of 
calcium  
2. TEST FOR SULPHATE 
2ml of the extract is added to 
5% barium chloride solution 
No white 
precipitate is 
formed  
Absence of 
Sulphate 
3. TEST FOR CHLORIDE 
The extract is treated with 
silver nitrate solution 
No white 
precipitate is 
formed  
Absence of 
chloride 
4. TEST FOR CARBONATE  
The substance is treated with 
concentrated HCL. 
No brisk effer 
vessence is formed  
Absence of 
Carbonate 
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5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution 
Blue colour is 
formed 
Indicates the 
presence of starch. 
6. TEST FOR IRON 
FERRIC: The extract is treated 
with glacial acetic acid and 
potassium ferro cyanide. 
No Blue color is 
formed 
Absence of ferric 
Iron 
7. TEST OF IRON FERROUS: 
The extract is treated with 
concentrated nitric acid and 
ammonium thio cynate 
No blood red 
colour is formed  
Absence of ferrous 
iron. 
8. TEST FOR PHOSPHATE 
The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed  
Absence of 
phosphate 
9. TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precipitate is 
formed 
Absence of 
Albumin. 
10. TEST FOR TANNIC ACID. 
The extract treated with Ferric 
Chloride reagent.  
No blue back 
precipitate is 
formed. 
Absence of Tannic 
acid. 
11. TEST FOR 
UNSATURATION 
Potassium permanganate 
solution is added to the extract. 
It gets 
decolourised. 
Indicates the 
presence of 
unsaturated 
compound. 
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12. TEST FOR THE 
REDUCING SUGAR. 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 mts 
and added 8-10 drops of the 
extract and again boil it for 2 
mts. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing Sugar. 
 
13. TEST FOR AMINO ACID. 
One or two drops of the extract 
is placed on a filter paper and 
dried it well after drying 1% 
Ninhydrin is sprayed over the 
same and dried it well. 
Violet colour is 
formed. 
Indicates the 
presence of Amino 
acid. 
14. TEST FOR ZINC 
The extract is treated with 
potassium Ferrocyanide 
No white 
precipitate is 
formed 
Absence of Zinc 
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ANNEXURE-III 
PHARMACOLOGICAL STUDIES 
ANTI – HISTAMINIC STUDY OF PERUMARAPATTAI    
CHOORANAM 
Aim: 
 To study the Anti – histaminic effect of Perumarapattai chooranam..  
Preparation of the test drug: 
 1gm of Perumarapattai chooranam was boiled with 20ml of water for 15 
minutes.  2ml of decoction was taken as the test drug.  
Procedure: 
 A guinea pig weighed about 350gm was starved for 48 hours.  It was 
sacrificed by a blow on the head and external jugular vein was allowed to bleed.  
The abdomen was then cut and ileum was cut out and placed in a tray which 
contained warm tyrode solution (370C) and continuously aerated.  The contents of 
the lumen of the ileum were washed and utmost care was taken to avoid any 
damage to the gut muscle.  An ileum segment having a length of about 3cm was 
taken and tied in both ends with thread.  One end was tied in a ‘j’ tube and the 
other end was tied in a frontal lever.  The tissue was put in an organ bath and the 
effects of drug on histamine induced contractions were recorded.  
Inference: The drug Perumarapattai Chooranam has significant Anti-histamine 
action.  
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ANTI HISTAMINE ACTION OF 
PERUMARAPATTAI CHOORANAM 
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ACUTE ANTI-INFLAMMATORY STUDIES OF 
PERUMARAPATTAI CHOORANAM 
Introduction:  
 In the Siddha System of Medicine, the drug under study is indicated in the 
condition of Karrappan Noi.  Therefore, it was through appropriate screening the 
drug for its acute inflammatory activity with the help of carrageenin induced Hind-
paw edema and for chronic anti-inflammatory activity cotton pellet granuloma 
method.  
Aim: 
 To evaluate the acute anti-inflammatory effect of Perumarapattai 
Chooranam by Carrageenin induced hind paw oedema method in Albino rats.  
Materials and Methods: 
 2 gms Perumarapattai Chooranam was suspended in 10ml of distilled water 
with gum acacia as suspending agent.  
Carrageenin induced Hind Paw Method: 
 Six healthy albino rats of either sex weighing between 80-100 gm were 
selected.  The volume of each hind paw was measured by using the mercury – 
plethysmograph.  
 After the measurement of hind paw of all the rats, they were divided into 
the groups each containing two rats.  
 First group was kept as control by giving distilled water 1ml/100gm of body 
weight.  The second group was given Ibuprofen 20mg/100gm body, weight and 
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kept as standard.  Third group was given test drug Perumarapattai Chooranam 
200gm/100gm body weight.  
 The drugs were administered orally.  One hour after drug administration, 
0.1ml 1% (w/v) of carrageenin suspension in water injected in the plantar surface 
of Hind Paw of all rats.  
 Three hour after carrageenin injection the hind paw volume was measured 
once again.  From the differences in the initial and final hind paw volume, the 
degree of the inflammation was calculated by taking the volume in the untreated 
control group as 100%. 
 The percentage of inflammation of the other group was calculated.  
Results: 
 The details of the experimental results shown in the table.  
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EFFECT OF PERUMARAPATTAI CHOORANAM  
Group Drugs 
Dose/ 
100gm of 
body weight 
Initial 
value 
Final 
value 
Mean 
difference 
% 
Inflammation 
% 
Inhibition 
Control Water 2ml 0.55 1.45 0.9 100 - 
Standard Ibuprofen 20mg/2ml 0.55 0.75 0.20 22.2 77.8 
 
Test Drug 
Perumarapattai 
Chooranam 
100mg/2ml 0.45 0.75 0.37 33.0 67.0 
 
Inference: 
 The test drug Perumarapattai Chooranam has Significant Acute Anti –
inflammtory action.  
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CHORNIC ANTI – INFLAMMATORY EFFECT OF  
PERUMARAPATTAI CHOORANAM 
Aim:  
 To evaluate the chronic anti-inflammatory effect of Perumarapattai 
Chooranam in rats by cotton pellets granuloma method.  
Materials and method: 
Drug preparation: 
 1gm of Perumarapattai Chooranam was suspended in 10ml of distilled 
water with gum acacia as suspending agent.  
Cotton pellect Granuloma method:  
Procedure: 
 Six healthy albino rats of either sex weighing between 80-100 gm were 
selected and divided into 3 groups each containing 2 rats.  
 In this procedure the drugs were given daily for 7 days.  Before giving the 
drug cotton pellets each weighing  10 mg were prepared and sterilized in an 
autoclave for about one hour under 15 Pounds atmospheric pressure.  
 On the day of experiment, each rat was anaesthetised with ether to implant 
10mg of sterilized cotton pellet subcutaneously in the lower abdomen two on each 
side after making suitable incision and sutured carefully.  
 First group was kept as control group by giving distilled water of 
2ml/100gm of body weight. To the second group the standard drug Ibuprofen in a 
does of 20mg/100gm of body weight was given.  
 The third group of animals was given tested drug Perumarapattai 
Chooranam in a dose of 200mg/100g of body weight.  
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 On the 8th day of the experiment, all the rats were sacrificed and cotton 
pellets found to be surrounded by granulation tissue were removed and dried in hot 
air oven at 550C-600C.  
Results: 
 The details of the experimental results are shown in the table.  
EFFECT OF PERUMARAPATTAI CHOORANAM 
Groups 
Dose/ 100gm 
body weight 
Pellet 
weight 
Pellet weight 
of the 
granuloma of 
drugs 
% 
inflammation 
% 
inhibition 
Water 1ml 10mg 250mg 100 - 
Ibu Brufen  20mg/2ml 10mg 55mg 22 78 
Perumarapattai 
 Chooranam 
2ml 10mg 125mg 50 50 
 
Result:  
 The test drug Perumarapattai Chooranam has Significant Chronic Anti – 
inflammatory action.  
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ACUTE ANTI-INFLAMMATORY STUDY OF 
PUNGU THYLAM (Externally) 
BY HINDPAW METHOD IN ALBINO RATS 
Procedure: 
 Anti-inflammatory activity of Pungu Thylam was studied in healthy albino 
rats. 
 Six rats were selected and divided into three groups. To the first group 
distilled water was given and kept as control. The second group was given the 
standard drug Ibuprofen at a dose of 20mg/ 100gm body weight. The third group 
was treated with the test drug externally. Before the application of the drug the 
hindpaw volume of all rats was measured. This was done by dipping the hindpaw 
upto the tibio dorsal junction in a mercury plethysmography. Subcutaneous 
injection of 0.1 ml of 1% w/v carrageenin in water was made into plantar surface 
of both the hindpaw of each rat. Three hours after injection, the hindpaw volume 
was measured once again. The difference between the initial and final volume 
would show the amount of inflammation. 
 Taking the volume in the control group as 100% of inflammation, the 
inflammatory or anti-inflammatory effect of the test group is calculated. 
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EFFECT OF PUNGU THYLUM 
Group Drugs 
Dose/ 
100gm of 
body 
weight 
Initial 
value 
Final 
value 
Mean 
difference 
% 
Inflammation 
% 
Inhibition 
Control Water 2ml 0.55 1.45 0.9 100 - 
Standard Ibuprofen 20mg/2ml 0.55 0.75 0.20 22.2 77.8 
Test Drug  
 
- 0.55 1.0 0.45 50.0 50.0 
Inference: 
 It is observed that Pungu Thylam has significant Acute Anti-inflammatory 
action. 
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ANNEXURE – 4 
ASSESSMENT FORM 
 
FORM l              -  SCREENING & SELECTION PROFORMA 
FORM l A          -  HISTORY PROFORMA ON ENROLLMENT 
FORM ll             -  CLINICAL ASSESSMENT ON ENROLLMENT 
FORM ll A         -  CLINICAL ASSESSMENT DURING & AFTER TRIAL 
FORM lll            -  LABORATORY     INVESTIGATION     ON   
     ENROLLMENT  & CONCLUSION OF TRIAL 
FORM IV           -  CONSENT FORM 
FORM IV A      -  WITHDRAWAL FORM 
FORM IV B       -  DRUG COMPLIANCE FORM 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI 
Branch – III Sirappu Maruthuvam 
A  PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF 
SIDDHA FORMULATION PERUMARAPATTAI CHOORANAM 
(INTERNAL) AND PUNGU THYLAM (EXTERNAL IN VATHA 
KARAPPAN (ECZEMA).   
 
FORM l - SCREENING & SELECTION PROFORMA 
 
1.  OP /IP NO:       
2.  NAME:  
3.  RELIGION: H / C / M / O                                          
4.  AGE/GENDER:              
 5.  OCCUPATION:    
6.  INCOME:            
7.  CONTACT NUM:  
8.  INCLUSION CRITERIA 
• Age :15-70 yrs 
• Sex : Both male and female 
• Willing to give specimen of blood for the investigation whenever 
required.  
•  Willing for admission and study in IPD for 40 days or willing to attend 
OPD 
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9. EXCLUSION CRITERIA: 
• Age below 15 and above 70 
• Pregnant and lactating women 
• Other than Eczema 
• STD  
• HIV 
 
ADMITTED TO TRAIL: 
If Yes Serial NO:     YES                   NO  
 
       
 
 
 
 
Date:        
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                            Signature of the HOD   
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI  
Branch – III Sirappu Maruthuvam 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF  SIDDHA  
FORMULATION   PERUMARAPATTAI CHOORANAM(INTERNAL) AND 
PUNGU THYLAM(EXTERNAL)  IN VATHA KARAPPAN (ECZEMA).  
                                  FORM l A -HISTORY PROFORMA 
 
1.  SI NO:          
2  OP /IP NO:      
3.  NAME :        
4. RELIGION : H / C / M / O                        
5. AGE/GENDER:                   
6.  OCCUPATION:         
7.  INCOME.:                      
8.  CONTACT NUM:   
9.  MARITAL STATUS:   Married/Unmarried        
10. COMPLAINTS & DURATION:   
                                                                                                                                                                
11. PERSONAL HISTORY: 
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         PERSONAL HABITS YES NO IF YES SPECIFY 
DURATION 
Smoking    
Tobacco Chewing    
Alcohol    
Narcotic  Drug Addiction    
 
12. DRUG HISTORY: Whether the Patient has underwent any allopathic 
Treatment           Yes/No,  
If yes specify the nature of the drug and treatment duration ……….. 
13. FAMILY HISTORY: 
 Whether this problem runs in family? 
                                               1. Yes                               2.No            
  If yes, mention the relationship of affected person(s) 
                                               1._________________ 
                                               2._________________ 
14.DIETARY HABITS     
                                1.Pure vegetarian           
2.Non-Vegetarian     
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                              Signature of the HOD 
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                   GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI 
Branch – III Sirappu Maruthuvam 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF 
SIDDHA FORMULATION PERUMARAPATTAI CHOORANAM 
(INTERNAL)  AND  PUNGU THYLAM(EXTERNAL) IN VATHA 
KARAPPAN ( ECZEMA). 
FORM II AND II-A CLINICAL ASSESSMENT ON ENROLLMENT AND 
ON VISITS 
 
1.   OP/ IP No:                                          
2.   BED No:                            
3.   Sl. No:  
 4.    NAME:                                             
           5.    AGE:                                
           6.    GENDER:  
 7.    OCCUPATION:                                       
            8.    SOCIAL STATUS: 
9.    DATE OF ADMISSION:                           
10.  DATE OF DISCHARGE: 
11.  POSTAL ADDRESS: 
12.  COMPLAINTS & DURATION:    
 13.  HISTORY OF PRESENT ILLNESS:  
14.  PAST HISTORY:  
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15.  FAMILY HISTORY: 
16.  MENSTRUAL HISTORY (If applicable):  
17.  HABITS: 
                                                                                                                                                                                                                                  
1. Smoker 
2. Alcoholic 
3. tobbaco chewer 
4. betel nut chewer 
5. Non-Vegetarian      
6. Drug addiction                                 
 
18. GENERAL EXAMINATION: 
1. Body weight [Kg]                          
2. Height [cm]                                        
3. Body Temperature [F]      
4. Blood Pressure (mmHg)   
5. Pulse Rate /min.        
6. Heart Rate /min.           
7. Respiratory Rate /min.   
8. Pallor   
9. Jaundice  
10. Clubbing 
11. Cyanosis  
12. Pedal Oedema  
13. Lymphadenopathy                                           
14. Jugular venous pulsation  
19. CLINICAL EXAMINATION: 
I.INSPECTION: 
• Size         
• Shape 
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• Colour 
• Border 
• Edge 
• Margin 
• Discharge 
 
II.PALPATION 
• Tenderness 
• Edge and margin 
• Surface 
 
III. CLINICAL ASSESSMENT:                                  
•  Erythema 
• Oozing 
• Itching 
• Vesicles 
• Pustules 
20. EXAMINATION OF OTHER SYSTEMS: 
           1.  CVS  
2.  RS    
3.  CNS 
4.  ABDOMEN   
5.  GENITO-URINARY                                      
EXAMINATION - SIDDHA ASPECTS 
1 . NILAM: 
             1. Kurinji     2. Mullai    3. Marutham  4. Neithal       5. Paalai 
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2 . KAALAM: 
            1. Kaar Kaalam    2. Koothir Kaalam        3. Munpani Kaalam      
            4. Pinpani Kaalam     5. Ilavenir Kaalam        6. Muduvenir Kaalam 
3. YAAKKAI: 
       1. Vatham      2. Pitham           3. Kabam     
       4. Vathapitham       5. Pithavatham    6. Kabavatham                                                                                   
       7. Vathakabam             8. Pithakabam                     9. Kabapitham    
4. GUNAM: 
      1. Sathuvam  2. Rasatham             3. Thamasam 
5. KANMENDHIRIUM / KANMAVIDAYAM 
               1. Kai                                           
2. Kaal                                           
3. Vaai                                            
4. Eruvaai                                       
5. Karuvaai                                     
6. UYIR THATHUKKAL: 
I. VATHAM:   
1.  Piraanan                                         
2. Abaanan                                          
3. Viyaanan                                                
4. Uthaanan                                         
5. Samaanan                                                                 
6. Naagan                                          
7. Koorman                                     
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8. Kirukaran                                           
9. Devathathan                                
         10. Dhananjeyan                             
II. PITHAM :            
1. Analam                                      
2. Ranjagam                                  
3. Saathagam                                       
4. Aalosagam                                         
5. Praasagam                                    
III. KABAM:                 
 1. Avalambagam                           
2. Kilethagam                               
3. Pothagam                                  
4. Tharpagam                                
5. Santhigam                                 
7. UDAL THAATHUKKAL: 
 1. Saaram                                               
2. Senneer             
3. Oon                                                        
4. Kozhuppu  
5. Enbu                                                       
6. Moolai                                                    
7. Sukkilam / Suronitham                           
8. ENVAGAI THERVUGAL: 
 1. Naadi     
 2. Sparisam                          
 3. Naa                                       
 4. Niram                                 
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5. Mozhi                                           
6. Vizhi                                             
7. Malam 
           Niram:     Thanmai:        Irugal:               Ilagal :                           
           8. Moothiram: 
    I. NEERKURI:  
     a. Niram   
     b. Manam      
     c. Edai                             
     d. Nurai    
     e. Enjal      
   II. NEIKURI:  
                  Vatha Neer             Pitha Neer            Kaba Neer 
 
 
 
Date:      
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                               Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI  
Branch – III Sirappu Maruthuvam 
 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF SIDDHA 
FORMULATION   PERUMARAPATTAI CHOORANAM(INTERNAL) AND 
PUNGU THYLAM(EXTERNAL)   IN VATHA KARAPPAN (ECZEMA).  
FORM lll - LABORATORY INVESTIGATION 
 
INVESTIGATION: 
     I.BLOOD: 
 
1.  TC :   (Cells/Cumm)          
2.  DC (%):   N     L        M        E                      
3.  ESR (mm) :    ½ hr ,1 hr 
4.  Hb: 
5.  Blood Sugar:   a) Fasting    b) Post Prandial c) Random                      
6.  Total RBC count 
7.  Serum cholesterol 
8.  Blood urea 
      9.  Serum creatinine 
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 2.URINE: 
• Albumin 
• Sugar 
• Deposits 
    II. SPECIFIC INVESTIGATIONS 
1. Skin scrapping test for fungus 
2. Bacterialand viral swab for microscophy and culture 
3. Patch and prick test 
4. Specific IgE test 
 
 
 
 
 
 
 
 
 
Date:         Station: 
 
 
Signature of the Investigator: 
Signature of the Lecturer:                                        Signature of the HOD 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI  
Branch – III Sirappu Maruthuvam 
                                     FORM IV A       - CONSENT FORM 
CERTIFICATE BY INVESTIGATOR 
            I certify that I have disclosed all the details about the study in the terms 
readily understood by the patient. 
                                                                                                
Signature………………… 
Date……… 
Name…………………… 
CONSENT BY PATIENT 
I have been informed to my satisfaction, by attending physician, the 
purpose of the clinical trial, and the nature of drug treatment and follow-up 
including the laboratory investigations to be performed to monitor and safeguard 
my body functions.  
I am aware of my right to opt out of the trial at any time during the course 
of the trial without having to give the reasons for doing so. 
I exercising my free power of choice, hereby give my consent to be 
included as a subject in the clinical trial of ‘Perumarapattai chooranam’ (internal) 
and ‘Pungu thylam’( external) in Vatha karappan.   
Place:                                                                                            Signature                                      
Date:                                                                                             Name 
                                                                                        
                                                                                                      Witness 
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murpdH rpj;j kUj;Jtf; fy;Y}hp kw;Wk; kUj;Jtkid 
ghisaq;Nfhl;il 
gl;lNkw;gbg;G rpwg;GkUj;Jtj;Jiw 
‘ngUkug;gl;il #uzk;;;;“ (cs;kUe;J) kw;Wk; ‘Gq;fvz;nza;“         
(ntspkUe;J) ,tw;wpd; gupfupg;Gj;jpwidf; fz;lwpAk; kUj;Jt 
Ma;TXg;Gjy; gbtk; Ma;thsuhy; rhd;wspf;fg;gl;lJ 
         ehd; ,e;j Ma;itf; Fwpj;j midj;J tpguq;fisAk; 
Nehahspf;F GupAk; tifapy; vLj;Jiuj;Njd; vd cWjpaspf;fpNwd;. 
Njjp:                                 ifnahg;gk;: 
,lk;:                                   ngau;: 
Nehahspapd; xg;Gjy; 
          vd;dplk; ,e;j kUj;Jt Ma;tpd; fhuzj;ijAk; kUe;jpd; jd;ik 
kw;Wk; kUj;Jt topKiwiag; gw;wpAk; njhlu;e;J vdJ cly; ,af;fj;ij 
fz;fhzp;f;fTk>; mjidg; ghJfhf;fTk; gad;gLk; kUj;Jt Ma;Tf;$l 
gupNrhjidfs; gw;wpAk; jpUg;jp mspf;Fk; tifapy; Ma;T kUj;Jtuhy; 
tpsf;fpf; $wg;gl;lJ. 
ehd; ,e;j kUj;Jt Ma;tpd; NghJ fhuzk; vJTk; $whky; 
vg;nghOJ Ntz;LkhdhYk; ,e;j Ma;tpypUe;J vd;id tpLtpj;Jf; 
nfhs;Sk; cupikia njupe;jpUf;fpd;Nwd;. 
        ehd; vd;Dila Rje;jpukhfj; Nju;T nra;Ak; cupikiaf; nfhz;L 
;thjfug;ghd; vd;Dk; Neha;f;fhd; ngUkug;gl;il #uzk;;;; “(cs;kUe;J) 
kw;Wk; ‘ Gq;fvz;nza; “(ntspkUe;J) ,tw;wpd;  gupfupg;Gj; jpwidf; 
fz;lwpAk; kUj;Jt Ma;tpw;F vd;id cl;gLj;j xg;Gjy; mspf;fpNwd;. 
 
Njjp:                                                 ifnahg;gk;: 
,lk;:                                                      ngau;: 
 
                               rhl;rpf;fhuh; ifnahg;gk;: 
                                                        ngau;: 
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GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI 
Branch – III Sirappu Maruthuvam 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF 
SIDDHA FORMULATION   PERUMARAPATTAI CHOORANAM 
(INTERNAL)  AND PUNGU THYLAM(EXTERNAL) IN VATHA 
KARAPPAN (ECZEMA). 
                            FORM IV B  - WITHDRAWAL FORM 
1. SI NO:          
2. OP /IP NO:     
3. NAME:      
4. RELIGION : H / C / M / O                        
5. AGE/GENDER:                       
6. OCCUPATION:        
7. SOCIAL STATUS:        
8. CONTACT NUM:     
9. DATE OF TRIAL COMMENCEMENT:  
10. DATE OF WITHDRAWAL FROM TRIAL:  
11. REASONS FOR WITHDRAWAL: 
       Long absence at reporting:                                               Yes/ No 
• Irregular treatment:                                                   Yes/ No 
• Shift of locality :                                                        Yes/ No 
• Increase in severity of symptoms:                     Yes/ No 
• Development of severe adverse drug reactions:   Yes/ No 
 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                              Signature of the HOD 
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      GOVERNMENT SIDDHA MEDICAL COLLEGE & HOSPITAL 
POST GRADUATE DEPARTMENT 
PALAYAMKOTTAI 
Branch – III Sirappu Maruthuvam 
A PILOT STUDY TO EVALUATE THE THERAPEUTIC EFFICACY OF 
SIDDHA FORMULATION   PERUMARAPATTAI CHOORANAM 
(INTERNAL) AND PUNGU THYLAM(EXTERNAL) IN VATHA 
KARAPPAN (ECZEMA).   
FORM IV C - DRUG COMPLIANCE FORM 
Name of the Drug:   PERUMARAPATTAI CHOORANAM (INTERNAL) AND 
PUNGU THYLAM (EXTERNAL)   
Drugs issued       :   (Mgs/Grams) 
Drugs returned  :   (Mgs/Grams) 
S.NO DATE 
DRUG TAKEN TIME 
MORNING/TIME EVENING/TIME 
Day 1    
Day 2    
Day 3    
Day 4    
Day 5    
Day 6    
Day 7    
Upto 48 Days    
 
After 7 days medicine 5 days resting period will be given to the patients. 
Date:          
Station: 
Signature of the Investigator: 
Signature of the Lecturer:                                                              
                                                                                   Signature of the    HOD 
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